<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82705</article-id><article-id pub-id-type="doi">10.7554/eLife.82705</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Proliferative exhausted CD8<sup>+</sup> T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-294293"><name><surname>Cheng</surname><given-names>Danni</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0368-6258</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-294294"><name><surname>Qiu</surname><given-names>Ke</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-294295"><name><surname>Rao</surname><given-names>Yufang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-294296"><name><surname>Mao</surname><given-names>Minzi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8777-6770</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-294297"><name><surname>Li</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294298"><name><surname>Wang</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294300"><name><surname>Song</surname><given-names>Yao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294302"><name><surname>Chen</surname><given-names>Junren</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295878"><name><surname>Yi</surname><given-names>Xiaowei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295880"><name><surname>Shao</surname><given-names>Xiuli</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295883"><name><surname>Huang</surname><given-names>Shao Hui</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295882"><name><surname>Zhang</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295884"><name><surname>Chen</surname><given-names>Xuemei</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295885"><name><surname>Wu</surname><given-names>Sisi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296000"><name><surname>Yu</surname><given-names>Shuaishuai</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296001"><name><surname>Liu</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296002"><name><surname>Wang</surname><given-names>Haiyang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296003"><name><surname>Peng</surname><given-names>Xingchen</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-296004"><name><surname>Li</surname><given-names>Daibo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296005"><name><surname>Yang</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-296006"><name><surname>Chen</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254322"><name><surname>Ying</surname><given-names>Zhiye</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296007"><name><surname>Zheng</surname><given-names>Yongbo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con23"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296008"><name><surname>Zheng</surname><given-names>Meijun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con24"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296009"><name><surname>Ying</surname><given-names>Binwu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con25"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296010"><name><surname>Zeng</surname><given-names>Xiaoxi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con26"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con27"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-296011"><name><surname>Xu</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con28"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-296012"><name><surname>Liu</surname><given-names>Geoffrey</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con29"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-296034"><name><surname>Chen</surname><given-names>Fei</given-names></name><email>hxchenfei@163.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con30"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-296035"><name><surname>Yu</surname><given-names>Haopeng</given-names></name><email>yuhaopeng@wchscu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con31"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-289572"><name><surname>Zhao</surname><given-names>Yu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1874-908X</contrib-id><email>yutzhao@VIP.163.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con32"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-294299"><name><surname>Ren</surname><given-names>Jianjun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5938-688X</contrib-id><email>Jianjun.Ren@scu.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con33"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/011ashp19</institution-id><institution>Department of Oto-Rhino-Laryngology, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/011ashp19</institution-id><institution>Institute of Clinical Pathology, West China Hospital, Sichuan University</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/011ashp19</institution-id><institution>Research Core Facility of West China Hospital, Sichuan University</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/011ashp19</institution-id><institution>West China Biomedical Big Data Center, West China Hospital, Sichuan University</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/011ashp19</institution-id><institution>Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff7"><label>7</label><institution>MinSheng Ear-Nose-Throat Hospital</institution><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/011ashp19</institution-id><institution>Department of Laboratory Medicine, West China Hospital, Sichuan University</institution></institution-wrap><addr-line><named-content content-type="city">Chengdu</named-content></addr-line><country>China</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03zayce58</institution-id><institution>Department of Biostatistics, Princess Margaret Cancer Centre and Dalla Lana School of Public Health</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03dbr7087</institution-id><institution>Department of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, University of Toronto</institution></institution-wrap><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Smith</surname><given-names>Kellie N</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>The Johns Hopkins University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Taniguchi</surname><given-names>Tadatsugu</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>University of Tokyo</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>22</day><month>02</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e82705</elocation-id><history><date date-type="received" iso-8601-date="2022-08-14"><day>14</day><month>08</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-02-01"><day>01</day><month>02</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-10-27"><day>27</day><month>10</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.10.27.513993"/></event></pub-history><permissions><copyright-statement>© 2023, Cheng, Qiu, Rao et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Cheng, Qiu, Rao et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82705-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-82705-figures-v1.pdf"/><abstract><p>The survival prognosis of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinoma (HNSCC) is largely different, and little is known about the anti-tumor mechanism of tumor-infiltrated exhausted CD8<sup>+</sup> T cells (Tex) in HNSCC. We performed cell-level multi-omics sequencing on human HNSCC samples to decipher the multi-dimensional characteristics of Tex cells. A proliferative exhausted CD8<sup>+</sup> T cell cluster (P-Tex) which was beneficial to survival outcomes of patients with HPV-positive HNSCC was identified. Interestingly, P-Tex cells expressed CDK4 genes as high as cancer cells, which could be simultaneously inhibited by CDK4 inhibitors and might be a potential reason for the ineffectiveness of CDK4 inhibitors in treating HPV-positive HNSCC. P-Tex cells could aggregate in the antigen-presenting cell niches and activate certain signaling pathways. Together, our findings suggest a promising role for P-Tex cells in the prognosis of patients with HPV-positive HNSCC by providing modest but persistent anti-tumor effects.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>tumor microenvironment</kwd><kwd>human papillomavirus</kwd><kwd>CDK4 inhibitor</kwd><kwd>proliferative exhausted CD8<sup>+</sup> T cells</kwd><kwd>head and neck squamous cell carcinoma</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004492</institution-id><institution>National Youth Foundation of China</institution></institution-wrap></funding-source><award-id>82002868</award-id><principal-award-recipient><name><surname>Ren</surname><given-names>Jianjun</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004492</institution-id><institution>National Youth Foundation of China</institution></institution-wrap></funding-source><award-id>32100927</award-id><principal-award-recipient><name><surname>Yu</surname><given-names>Haopeng</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002858</institution-id><institution>China Postdoctoral Science Foundation</institution></institution-wrap></funding-source><award-id>2020M673250</award-id><principal-award-recipient><name><surname>Ren</surname><given-names>Jianjun</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Sichuan Province Science and Technology Support Program</institution></institution-wrap></funding-source><award-id>2022YFS0066</award-id><principal-award-recipient><name><surname>Zheng</surname><given-names>Yongbo</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Sichuan Province Science and Technology Support Program</institution></institution-wrap></funding-source><award-id>2020YFS0111</award-id><principal-award-recipient><name><surname>Ren</surname><given-names>Jianjun</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Sichuan Province Science and Technology Support Program</institution></institution-wrap></funding-source><award-id>2021YFS0158</award-id><principal-award-recipient><name><surname>Yu</surname><given-names>Haopeng</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>West China Hospital, Sichuan University</institution></institution-wrap></funding-source><award-id>ZYJC21027</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Yu</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>West China Hospital, Sichuan University</institution></institution-wrap></funding-source><award-id>2019HXBH079</award-id><principal-award-recipient><name><surname>Ren</surname><given-names>Jianjun</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004912</institution-id><institution>Sichuan University</institution></institution-wrap></funding-source><award-id>2020SCU12049</award-id><principal-award-recipient><name><surname>Ren</surname><given-names>Jianjun</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009579</institution-id><institution>Health Department of Sichuan Province</institution></institution-wrap></funding-source><award-id>20PJ030</award-id><principal-award-recipient><name><surname>Ren</surname><given-names>Jianjun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Multi-omic profiling of tumor-infiltrating T cells provides new insights into the differences in the effectiveness of CDK4 inhibitor between human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinoma patients.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The incidence of head and neck squamous cell carcinoma (HNSCC) has continued to rise and an annual increase of 1.08 million new cases is estimated by 2030, which is greatly attributed to the increasing rates of human papillomavirus (HPV) infection (<xref ref-type="bibr" rid="bib12">Bray et al., 2018</xref>; <xref ref-type="bibr" rid="bib17">Ferlay et al., 2019</xref>; <xref ref-type="bibr" rid="bib36">Näsman et al., 2020</xref>). HPV-positive HNSCC and HPV-negative HNSCC displayed markedly different characteristics from pathogenesis to treatment outcomes and are visualized as two distinct clinical entities (<xref ref-type="bibr" rid="bib5">Ang et al., 2010</xref>; <xref ref-type="bibr" rid="bib47">Wansom et al., 2010</xref>).</p><p>T cell exhaustion within the tumor microenvironment (TME) is a newly discovered phenomenon resulting from persistent antigen stimulation from chronic virus infection or tumors, in which tumor-infiltrated CD8<sup>+</sup> T cells experience gradual alterations in their functional capacity while highly expressing multiple inhibitory receptors, including PD1, TIM3, LAG3, CTLA4, and TIGIT (<xref ref-type="bibr" rid="bib48">Wherry and Kurachi, 2015</xref>; <xref ref-type="bibr" rid="bib10">Blank et al., 2019</xref>). Recent studies have revealed that heterogeneity is a hallmark of T cell exhaustion, and several distinct subsets of exhausted CD8<sup>+</sup> T cells (Tex) have been identified, each with unique gene signatures, functional characteristics, and epigenetic modifications (<xref ref-type="bibr" rid="bib35">Miller et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Beltra et al., 2020</xref>). Meanwhile, specific transitions among those subsets have also been illustrated under certain circumstances and might be associated with retained effector function and enforced tumor control (<xref ref-type="bibr" rid="bib23">Im et al., 2016</xref>; <xref ref-type="bibr" rid="bib28">Kim et al., 2020</xref>). However, how T cell exhaustion affects the prognosis of HNSCC patients and how it differs in HPV-positive and HPV-negative HNSCC remain to be further clarified.</p><p>Recently, there has been increasing evidence showing that HPV-positive HNSCC displays a T cell-inflamed phenotype distinct from its HPV-negative counterparts, indicating that HPV infection is associated with increased T cell infiltration and effector cell activation (<xref ref-type="bibr" rid="bib19">Gameiro et al., 2018</xref>; <xref ref-type="bibr" rid="bib46">Wang et al., 2019</xref>). Meanwhile, HPV infection has also been proven to be associated with T cell exhaustion, in which HPV-positive HNSCC expressed higher levels of multiple T cell exhaustion markers such as PD1, TIM3, LAG3, and TIGIT compared to HPV-negative HNSCC, suggesting of stronger antigen-specific T cell immunity in HPV-positive HNSCC (<xref ref-type="bibr" rid="bib19">Gameiro et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Kansy et al., 2017</xref>). However, more sophisticated T cell landscapes related to the HPV status of HNSCC remain to be further clarified.</p><p>Cyclin-dependent kinase 4 (CDK4) inhibitors are introduced as novel drugs by targeting and disrupting the CDK4-related cell cycle progression of cancer cells in recent years (<xref ref-type="bibr" rid="bib20">Goel et al., 2018</xref>; <xref ref-type="bibr" rid="bib15">Deng et al., 2018</xref>). However, promising treatment outcomes of CDK4 inhibitors were only observed in HPV-negative HNSCC rather than HPV-positive HNSCC (<xref ref-type="bibr" rid="bib1">Adkins et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Oppelt et al., 2021</xref>; <xref ref-type="bibr" rid="bib44">van Caloen and Machiels, 2019</xref>) due to the mutation differences of cell cycle-related genes in cancer cells, and less attention has been paid to the effects of CDK4 inhibitors on infiltrating T cells.</p><p>To address these questions, we applied cell-level multi-omics sequencing techniques to decipher the multi-dimensional characterization of tumor-infiltrating T cells and its association with overall survival (OS) in human HNSCC with different HPV status.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>P-Tex cells were identified in the transcriptomic landscape of T cells in HNSCC patients</title><p>To decipher the multi-dimensional characterization of tumor-infiltrating T cells in human HNSCC, we integrated multi-omics sequencing based on 5’ droplet-based single-cell RNA (scRNA-seq), single-cell TCR sequencing (scTCR-seq), and spatial transcriptomics in HNSCC samples (mainly oropharyngeal cell carcinoma, the most representative type of HPV-related HNSCC), and further verified in vitro (n=24, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> and <xref ref-type="fig" rid="fig1">Figure 1a</xref>). A total of 49,813 CD3<sup>+</sup> T cells in 14 paired HNSCC tumor and normal adjacent samples were obtained after quality control. And 11 T cell clusters with distinct gene signatures were defined (<xref ref-type="fig" rid="fig1">Figure 1b</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>), including four CD8<sup>+</sup> T cell clusters (C1, C4, C7, and C9), five CD4<sup>+</sup> T cell clusters (C2: naïve CD4<sup>+</sup> T cells, C3: regulatory T cells [Treg], C5: T helper cells, C8: CD4-Tex, and C10: T follicular helper cells), one γδ T cell cluster (C6), and one double negative T cell cluster (C0: DN, CD4<sup>-</sup>CD8<sup>-</sup>), with marker genes (<xref ref-type="bibr" rid="bib13">Brummelman et al., 2018</xref>) shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The P-Tex cell clusters identified in the T cell landscapes of head and neck squamous cell carcinoma (HNSCC) patients by single-cell RNA sequencing (scRNA-seq).</title><p>(<bold>a</bold>) The flow chart of this study. (<bold>b</bold>) Uniform manifold approximation and projection (UMAP) plot of all single T cells from 14 samples via 10× Genomics. Eleven T cell clusters with different functions are identified. (<bold>c</bold>) Dotplot of selected T cell function-associated genes across different T cell clusters, showing both gene expression level (the color gradient) and the percentage of cells (the size of circle) in a given cluster. (<bold>d</bold>) Pie charts of cell-type fractions identified in cancer and normal adjacent tissues, colored by cell types. (<bold>e</bold>) The kernel density estimation plot showing the distribution of MKI67 and CDK4 genes of T cells. (<bold>f</bold>) The gene expression levels of CDK4 and MKI67 shown by violin plots. (<bold>g</bold>) Heatmap of the transcriptional regulators of top expressed genes in each T cell clusters.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The extended summary of functional properties of T cell clusters in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>(<bold>a</bold>) The distribution of T cells in cancer and adjacent normal tissues in uniform manifold approximation and projection (UMAP) plots. (<bold>b</bold>) The distribution of T cells in each patient in UMAP plots. (<bold>c</bold>) The distribution of cell proportions in each sample.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig1-figsupp1-v1.tif"/></fig></fig-group><p>We specifically characterized marker genes of CD8<sup>+</sup> T cell into several panels based on their canonical biological function (proliferation, exhaustion, and cytotoxicity, shown in <xref ref-type="fig" rid="fig1">Figure 1c</xref>). Among the four CD8<sup>+</sup> T cell clusters, C1 was characterized by expressing multiple effector genes, including <italic>NKG7</italic>, <italic>GZMH</italic>, <italic>IFNG,</italic> and <italic>KLRG1</italic>, with a high cytotoxicity score but a low exhaustion score, thus representing effective CD8<sup>+</sup> T cell (Teff) (<xref ref-type="bibr" rid="bib18">Galletti et al., 2020</xref>). C4 showed high expression of checkpoint marker genes, including <italic>PDCD1</italic>, <italic>HAVCR2</italic>, <italic>LAG3</italic>, and <italic>TNFRSF9</italic>, with both high cytotoxicity and exhaustion scores, which was consistent with the cell identity of terminally differentiated exhausted CD8<sup>+</sup> T cells (T-Tex) (<xref ref-type="bibr" rid="bib48">Wherry and Kurachi, 2015</xref>). Notably, in addition to high expression of the above-mentioned checkpoint marker genes, C7 and C9 also displayed high expression levels of cell cycle-related genes, including <italic>CCNA2</italic>, <italic>UBE2C,</italic> and <italic>CDK4</italic>, as well as stem-like genes <italic>MKI67</italic> (marker gene of proliferation) and <italic>ASPM</italic> (involved in regulation of the mitotic spindle and coordination of mitotic processes), with high cytotoxicity, exhaustion, and proliferation genes, featuring a gene expression profile reminiscent of a previously reported Tex subset with high proliferative capacity (<xref ref-type="bibr" rid="bib45">Wagle et al., 2021</xref>), which we defined as P-Tex in the present study.</p><p>Meanwhile, T cells appeared to exhibit distinct tissue distributions, with higher proportions of Treg, Teff, T-Tex, and P-Tex cells being observed in tumor tissues while more DN and CD4-Tex cells being observed in adjacent normal tissues (<xref ref-type="fig" rid="fig1">Figure 1d</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>). To evaluate individual heterogeneity, we further clustered the cells of each HNSCC sample and confirmed the existence of all cell clusters across all samples (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b–c</xref>).</p><p>Notably, the P-Tex cluster (~2819 cells) could be further partitioned into two subclusters, which we annotated as P-Tex1 and P-Tex2. More specifically, <italic>CDK4</italic> (a canonical cell cycle-related marker gene) was mainly expressed in P-Tex2, whereas <italic>MKI67</italic> (the most canonical marker gene for proliferation) was mainly expressed in P-Tex1 (<xref ref-type="fig" rid="fig1">Figure 1e–f</xref>), indicating that these two cell clusters might fulfill their proliferative capacity through different mechanisms. Moreover, to further investigate the potential upstream regulatory mechanisms in shaping the molecular characteristics of each unique T cell cluster, we analyzed the transcription factor networks that driving the expression of the top expression genes in each T cell cluster (shown in <xref ref-type="fig" rid="fig1">Figure 1g</xref> and <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Specifically, MYBL2, BRCA1, E2F1, E2F8, EZH2, and TFDP1 were the identified upstream regulatory transcription factors that predominantly drove the expression of proliferation-related genes of P-Tex1 and P-Tex2.</p><p>Taken together, our clustering strategy generated 11 distinct T cell clusters in HNSCC, among which P-Tex cells with both exhausted and proliferative phenotypes were identified.</p></sec><sec id="s2-2"><title>Functional characteristics of P-Texs</title><p>To further investigate the functional characteristics of P-Tex cells, we characterized the function of marker genes by comparing with Teff and T-Tex clusters. Specifically, gene ontology (GO) enrichment analysis showed that T cell activation, lymphocyte differentiation, and viral gene expression were enriched in all three Tex cell clusters, whereas the regulation of the cell cycle, apoptosis, and certain immune responses were enriched in P-Texs, showing divergent functional specialization (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). Meanwhile, the activation states of CD8<sup>+</sup> T cell subpopulations were quantitatively assessed based on the average expression of previously described activation-related gene signatures (<xref ref-type="bibr" rid="bib7">Azizi et al., 2018</xref>) (also shown in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Our results showed that the T-Tex cluster was the most activated, followed by the two P-Tex clusters (<xref ref-type="fig" rid="fig2">Figure 2b</xref>, left). In addition, CD8<sup>+</sup> T cells in tumor tissues were more activated than those in adjacent normal tissues (<xref ref-type="fig" rid="fig2">Figure 2b</xref>, right top). And no significant difference in T cell activation states was observed between HPV-positive and HPV-negative samples (<xref ref-type="fig" rid="fig2">Figure 2b</xref>, right bottom).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The comparison of functional characteristics between P-Texs and other CD8<sup>+</sup> T cell clusters.</title><p>(<bold>a</bold>) Gene ontology (GO) analysis of differentially expressed genes in each CD8<sup>+</sup> T cell clusters, colored by cell types. (<bold>b</bold>) The T cell activation score of each CD8<sup>+</sup> T cell clusters. T cell activation score defined as the averaged expression of genes in the activation signature in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. Statistics were assessed by Dunn's tests. (<bold>c</bold>) The gene set enrichment analysis (GSEA) diagrams show the enrichment profiles of cell cycle pathway in each CD8<sup>+</sup> T cell clusters. (<bold>d–f</bold>) The distribution and scores of cell cycle phases of each CD8<sup>+</sup> T cells. (<bold>g</bold>) The proliferation, exhaustion, and cytotoxic scores of each CD8<sup>+</sup> T cell clusters. Proliferation score: averaged expression of MKI67-related genes; exhaustion score: averaged expression of PDCD1-related genes; cytotoxic score: averaged expression of GZMB-related genes. (<bold>h</bold>) The Kaplan–Meier curves show the overall survival rate of HPV<sup>+</sup>/HPV<sup>-</sup> head and neck squamous cell carcinoma (HNSCC) patients with different proliferation, exhaustion, and cytotoxic scores in The Cancer Genome Atlas (TCGA) cohort, adjusted for age and gender. ***: p&lt;0.001, **: p&lt;0.01, *: p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig2-v1.tif"/></fig><p>Additionally, to further confirm that P-Texs displayed high cell cycle-related function, we performed gene set enrichment analysis (GSEA) using the gene set that represents the cell cycle pathway, and the results showed that two P-Tex clusters were more enriched in the cell cycle signal pathway than the T-Tex and Teff clusters (p&lt;0.001, <xref ref-type="fig" rid="fig2">Figure 2c</xref>). To further investigate the cell cycle phase of each T cell cluster, we calculated cell cycle scores and visualized them on uniform manifold approximation and projection (UMAP) plots (<xref ref-type="fig" rid="fig2">Figure 2d</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). P-Tex1 was mainly in G2/M phase, indicating cells were under a proliferative burst, which was consistent with the high expression of proliferation marker gene <italic>MKI67</italic> (<xref ref-type="bibr" rid="bib9">Bertoli et al., 2013</xref>), whereas P-Tex2 was mainly in S phase, an essential phase for DNA replication before undergoing mitosis, which was consistent with the high expression of <italic>CDK4</italic> (initiating the G1 to S phase transition) (<xref ref-type="fig" rid="fig2">Figure 2e–f</xref>; <xref ref-type="bibr" rid="bib9">Bertoli et al., 2013</xref>; <xref ref-type="bibr" rid="bib41">Romero-Pozuelo et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Rubin et al., 2020</xref>). Taken together, P-Tex1 and P-Tex2 might represent proliferation cells in two distinct cell cycle phases.</p><p>It is also noteworthy that HPV-positive HNSCC patients in TCGA (The Cancer Genome Atlas) cohort with higher P-Tex score (5-year OS: 55.8% vs. 22.6%, p=0.02), proliferation score (<italic>MKI67-</italic>related genes, 5-year OS: 49.1% vs. 15.8%, p&lt;0.001), exhaustion score (<italic>PDCD1-</italic>related genes, 5-year OS: 56.2% vs. 23.1%, p=0.05), or cytotoxic score (<italic>GZMB</italic>-related genes, 5-year OS: 55.4% vs. 21.9%, p=0.02) had better survival outcomes, whereas similar trends were not observed in HPV-negative HNSCC patients (<xref ref-type="fig" rid="fig2">Figure 2g–h</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). It is probably related to the difference in TME between HPV<sup>+</sup> vs. HPV<sup>-</sup> HNSCC.</p><p>Taken together, the P-Tex cluster displayed high expression levels of proliferation- and cell cycle-related genes. More importantly, HPV-positive HNSCC patients with higher P-Tex score, proliferation score, exhaustion score, or cytotoxic score had better survival outcomes, while this trend was not observed in HPV-negative HNSCC patients.</p></sec><sec id="s2-3"><title>Paired scRNA-seq and TCR-seq revealed the developmental trajectory of P-Tex</title><p>Given the clonal accumulation of CD8<sup>+</sup> T cells was a result of local T cell proliferation and activation in the tumor environment (<xref ref-type="bibr" rid="bib43">Tanchot et al., 2013</xref>), we further conducted clonality analysis of CD8<sup>+</sup> T cells based on TCR-seq data. After quality control, we obtained TCRs with both alpha and beta chains for 33,897 T cells, including 20,607 unique TCRs, 2798 double TCRs, and 10,492 clonally expanded TCRs, with clonal sizes ranging from 2 to 162.</p><p>To further confirm whether the T cell clonality was associated with TME and HPV status, we systematically compared the clonality by cell clusters, tissue origin, and HPV status, respectively. The CD8<sup>+</sup> T cell clusters harbored more clonally expanded cells than CD4<sup>+</sup> T cell clusters and DN cell clusters in general, among which Tex harbored the highest proportions of clonal cells, followed by the two P-Tex clusters, which were more abundant than the Teff cells (<xref ref-type="fig" rid="fig3">Figure 3a–b</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a–b</xref>). Our results showed that hyperexpanded TCR clonotypes were more enriched in tumors than adjacent normal tissues (<xref ref-type="fig" rid="fig3">Figure 3c–d</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1c–d</xref>). However, the proportions of hyperexpanded TCR clonotypes of Teff, P-Tex1, and T-Tex showed no significant difference between HPV-positive samples and HPV-negative samples (<xref ref-type="fig" rid="fig3">Figure 3e–f</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1e–f</xref>). Correspondingly, a higher diversity of TCRs was observed in adjacent normal tissues and HPV-negative samples (<xref ref-type="fig" rid="fig3">Figure 3g</xref>), indicating the absence of a strong antigen-specific immune response, which further confirmed the crucial roles of virus and tumor play in local T cell proliferation and activation (<xref ref-type="bibr" rid="bib22">Hwang et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Poropatich et al., 2017</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The developmental trajectory and lineage relationships among T cell clusters.</title><p>(<bold>a–f</bold>) Single-cell TCR profiling of head and neck squamous cell carcinoma (HNSCC) in all samples (<bold>a–b</bold>), cancer tissues vs. normal tissues (<bold>c–d</bold>), HPV<sup>+</sup> vs. HPV<sup>-</sup> (<bold>e–f</bold>). Bar plots show the fractions of each clonotype frequencies. The clonotype frequencies are defined as unique (n=1), double (n=2), multiple clones (2 &lt; n ≤ 20), and hyper clones (20 &lt; n ≤ 200) according to the numbers of clonotypes. (<bold>g</bold>) The TCR diversity of cancer tissues vs. normal tissues and HPV<sup>+</sup> vs. HPV<sup>-</sup> samples, calculated using Shannon metric. (<bold>h–i</bold>) Cell state transition of T cell clusters inferred by shared TCRs. The chord diagram (<bold>h</bold>) showing the fraction of shared clonotypes among each cell clusters. Lines connecting different clusters are based on the degree of TCR sharing, with the width of lines representing the number of shared TCRs. The clonal overlap diagram (<bold>i</bold>) measures the clonal similarity among each cluster. Color gradient in the grid refers to the overlap coefficient. The higher the index score, the higher the clonal diversity. (<bold>j–l</bold>) Potential developmental trajectory of T cells inferred by Monocle3 based on gene expressions.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Extended summary of TCR properties of <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title><p>The supplementary comparison of the clonotype frequencies of clusters in each cluster (<bold>a–b</bold>), cancer tissues vs. normal tissues (<bold>c–d</bold>), HPV<sup>+</sup> vs. HPV<sup>-</sup> (<bold>e–f</bold>) ; statistics were assessed by Chi-square tests.The clonotypes are defined as unique (n=1), double (n=2), multiple (2 &lt; n ≤ 20), and hyper clonal (20 &lt; n ≤ 200) according to their clonotype numbers. The clonalOverlay diagrams show the clonal expansion in HPV<sup>+</sup> vs. HPV<sup>-</sup> and cancer tissues vs. normal tissues by overlaying the cells with specific clonal frequency onto the uniform manifold approximation and projection (UMAP) plots in Seurat (<bold>c and f</bold>). The density contours indicate the frequencies of TCR, with the number of clones ≥3 to be the cutoff value of the outermost circle layer, and the most central circle layer represents the area with the highest TCR expansion. (<bold>g–j</bold>) The distribution of shared CD8<sup>+</sup> clones on the UMAP plot. Colored dots were CD8<sup>+</sup> T cells of identical clonotypes. The colored circles highlight the cluster information of each cell, as defined in <xref ref-type="fig" rid="fig1">Figure 1a</xref>, with fractional Teff, T-Tex, and P-Tex cells sharing the same TCRs shown in colors. Bar charts show the proportion of the each clonotype in each cluster (<bold>h</bold>), samples (<bold>i</bold>), and different human papillomavirus (HPV) status (<bold>j</bold>), respectively. ***: p&lt;0.001, **: p&lt;0.01, *: p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Extended summary of TCR clonotypes and potential differentiation direction of <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title><p>(<bold>a–c</bold>) The frequency of clonotypes and TCR distribution of CD8<sup>+</sup> T cells across individuals (<bold>a</bold>), HPV<sup>+</sup>/HPV<sup>-</sup> samples (<bold>b</bold>), and cancer/normal samples (<bold>c</bold>). Frequencies of TCRs are labeled with gradient colors. Pie charts below each bar illustrate the TCR composition of each CD8 cluster. (<bold>d</bold>) The 3D developmental trajectories of T cells show the potential differentiation direction of each cluster.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig3-figsupp2-v1.tif"/></fig></fig-group><p>We further examined the TCR clonotype occupation among each cluster and revealed that most of the shared TCRs were observed among the T-Tex, P-Tex, and Teff clusters (<xref ref-type="fig" rid="fig3">Figure 3h–i</xref>, <xref ref-type="supplementary-material" rid="supp6 supp7">Supplementary files 6-7</xref>). The Teff cluster had higher proportion of TCRs shared with the γδ T (overlap coefficient, oc = 0.49), Tex (oc = 0.43), P-Tex2 (oc = 0.35), and P-Tex1 (oc = 0.33) clusters, respectively, indicating they had common ancestry of origin. Besides, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1g–j</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2a–c</xref> show the distribution of the top shared clonotypes across CD8<sup>+</sup> T cell clusters, individuals, and HPV status. There were almost no shared TCRs across individuals, indicating the highly heterogeneous characteristics of T cells among individuals.</p><p>To further investigate their lineage relationships, we performed pseudotime analysis for CD3<sup>+</sup> T cells on the basis of transcriptional similarities (<xref ref-type="fig" rid="fig3">Figure 3j–l</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2d</xref>). The starting point of pseudotime was the DN cluster, with CD4<sup>+</sup> T cell and CD8<sup>+</sup> T cell clusters differentiating toward two different directions, suggesting of their distinct developmental paths. Notably, two P-tex clusters primarily aggregated at the end of the pseudotime backbone of CD8<sup>+</sup> T cells, and presented to be a specific branch originating from T-Tex, demonstrating its specific activation state and characteristic, which was distinct from other T-Tex cells. Besides, P-Tex2 was located ahead of P-Tex1 on the pseudotime, which was consistent with the results in <xref ref-type="fig" rid="fig2">Figure 2d–e</xref>, where P-Tex2 cells mainly entered the S phase of the cell cycle (early phase), while P-Tex1 mainly entered the G2/M phase (later phase).</p><p>Taken together, given that two P-Tex clusters were located at the end of the developmental trajectory of the Teff and T-Tex cells and that P-Tex clusters partially shared TCRs with the T-Tex cluster, we speculated that Teff cells transformed from an activated to exhausted state (T-Tex cells), and some of the T-Tex cells could further gradually transform into a unique P-Tex subpopulation with a highly specific proliferation state.</p></sec><sec id="s2-4"><title>The survival, proliferation capacity, and cytotoxicity of P-Texs in vitro</title><p>To further verify the aforementioned function of P-Tex cells, we sorted P-Tex cells (CD3<sup>+</sup>CD8<sup>+</sup>UBE2C<sup>+</sup>PD1<sup>+</sup>) and T-Tex cells (CD3<sup>+</sup>CD8<sup>+</sup>UBE2C<sup>-</sup>KLRB1<sup>+</sup>PD1<sup>+</sup>) via flow cytometry to compare their functions in vitro (<xref ref-type="fig" rid="fig4">Figure 4a–g</xref>). Unexpectedly, our flow cytometry results showed that the proliferation rate of P-Tex cells cultured with IL-2 for 15 and 20 days in vitro was much slower than that of T-Tex cells (<xref ref-type="fig" rid="fig4">Figure 4a</xref>), whereas the cell viability of P-Tex cells was much higher than that of T-Tex cells (<xref ref-type="fig" rid="fig4">Figure 4b–c</xref>), indicating that instead of showing high proliferation capacity when stimulated in vitro, the P-Tex cells were mainly characterized by prolonged cell survival.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The survivaland proliferation capacity of P-Texs in vitro.</title><p>Comparing the proliferation (<bold>a</bold>) and survival (<bold>b–c</bold>) capacity of P-Tex and T-Tex cells cultured with IL-2 for 15 and 20days in vitro measured by CCK8 experiment; proliferation experiment, shown by the mean ± SEM. (<bold>d–g</bold>) Representative flow cytometry assay of UBE2C, PD1, and KLRB1 of P-Tex cells after 9 and 15 days of stimulation with anti-CD3/CD28 microbeads in vitro. (<bold>d</bold>) The gating strategies of PD1, KLRB1, and UBE2C. (<bold>e–g</bold>) Mean fluorescence intensity (<bold>e</bold>) and cell count (<bold>f–g</bold>) of UBE2C, PD1, and KLRB1 in P-Tex and T-Tex cells at different days detected by flow cytometry. (<bold>h</bold>) Histogram of activation states of P-Tex and Tex cells by single-cell RNA-seq data.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig4-v1.tif"/></fig><p>Moreover, P-Tex cells expressed higher levels of proliferation-related marker UBE2C, as measured by flow cytometry, and the variations of UBE2C in P-Tex and T-Tex cells between 9 and 16 days were relatively stable (<xref ref-type="fig" rid="fig4">Figure 4d–g</xref>). Besides, compared with T-Tex cells, P-Tex cells expressed higher exhaustion-related markers (PD1), and the expression of PD1 in P-Tex and T-Tex cells gradually increased from day 9 to day 16. Meanwhile, a larger proportion of T-Tex cells produced more cytotoxic-related markers (KLRB1) than P-Tex cells after stimulated with CD3/CD28 microbeads and IL-2 for 9 and 16 days in vitro, whereas the expression of KLRB1 in T-Tex gradually decreased since day 9, and the expression of KLRB1 in P-Tex was relatively stable. Meanwhile, the results of our in vitro experiments were consistent with the aforementioned findings showing that the T-Tex cells were more activated than those of P-Tex cells (<xref ref-type="fig" rid="fig4">Figure 4h</xref>).</p><p>Taken together, P-Tex cells represent a unique subcluster of the exhausted CD8<sup>+</sup> T cells, which was characterized by prolonged cell survival in vitro and could provide modest but persistent anti-tumor effects.</p></sec><sec id="s2-5"><title>The effect of CDK4 inhibitor on P-Tex cells might be a reason for its ineffectiveness in HPV-positive HNSCC patients</title><p>To better understand the anti-tumor role of P-Tex within the TME, we additionally conducted 5’ droplet-based scRNA-seq profiles (10× Genomics) for primary tumors with paired adjacent normal tissues from two HNSCC patients. All biopsies were histologically examined by two independent pathologists. After quality control, a total of 13,515 cells from tumors (9040 cells) and adjacent normal tissues (4476 cells) were obtained. Given the fact that higher heterogeneity of cellular compositions exists in the TME than pure T cells, we recategorized all cells into 20-cell clusters according to previously reported markers (<xref ref-type="fig" rid="fig5">Figure 5a</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a</xref>, <xref ref-type="supplementary-material" rid="supp8">Supplementary file 8</xref>). We consistently identified that P-Tex cells highly expressed proliferation- and cell cycle-related genes and functions as the cancer epithelial cluster (<xref ref-type="fig" rid="fig5">Figure 5b</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1b–d</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The expression of CDK4 gene in P-Tex2 cluster is associated with the treatment outcomes of HPV<sup>+</sup> head and neck squamous cell carcinoma (HNSCC) patients.</title><p>(<bold>a</bold>) Single-cell transcriptomic profiling of HNSCC tumor microenvironment (TME). Twenty cell clusters are identified, colored by cell types. (<bold>b</bold>) The proliferation status of P-Tex and epithelial cells in violin plot. (<bold>c</bold>) The kernel density estimate distribution of proliferation markers (CDK4 and MKI67) and epithelial cancer cell markers (KRT15 and CD24) in uniform manifold approximation and projection (UMAP) plots. (<bold>d</bold>) The overall survival rate of HPV<sup>+</sup>/HPV<sup>-</sup> HNSCC patients in The Cancer Genome Atlas (TCGA) cohort related to the expression levels of CDK4 gene, adjusted for age and gender. (<bold>e</bold>) The proportion of P-Texs, T-Tex, and TEFF clusters in HPV<sup>+</sup> and HPV<sup>-</sup> samples in TCGA cohort by using the deconvolution algorithm; statistics were assessed by Chi-square tests. Marker genes that were used to define cell clusters in (<bold>a</bold>) are deconvolved into the TCGA data to obtain the proportion of P-Texs, T-Tex, and Teff clusters in the TCGA cohort. (<bold>f</bold>) The cell viability of P-Tex and cancer epithelial cells assessed by CCK8 experiment after Abemaciclib treated in vitro. ***: p&lt;0.001, **: p&lt;0.01, *: p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>The extended summary of functional properties of cell clusters in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title><p>(<bold>a</bold>) Average expression of selected T cell function-associated genes across different cell clusters. (<bold>b</bold>) Gene ontology (GO) analysis of differentially expressed genes in two P-Tex and cancer epithelial cell clusters. (<bold>c</bold>) The gene set enrichment analysis (GSEA) diagrams show the enrichment of cell cycle genes in P-Tex clusters and cancer epithelia cluster. (<bold>d</bold>) The proliferation status of each T cell cluster; statistics were assessed by Dunn's tests. ***: p&lt;0.001, **: p&lt;0.01, *: p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>The extended summary of function properties of cell clusters in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title><p>(<bold>a</bold>) The distribution of cells in cancer and normal tissues in uniform manifold approximation and projection (UMAP) plots. (<bold>b</bold>) The proportion of each cell cluster in all samples, cancer vs. normal tissue samples, and individual samples, colored by cell types. (<bold>c</bold>) Comparing the proportion of P-Texs, T-Tex, and Teff clusters in HPV<sup>+</sup> and HPV<sup>-</sup> samples in single-cell sequencing data; statistics were assessed by Chi-square tests. ***: p&lt;0.001, **: p&lt;0.01, *: p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig5-figsupp2-v1.tif"/></fig></fig-group><p>P-Tex clusters were predominantly tumor-derived (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2a–b</xref>) cells. We further investigated the expression and distribution of proliferation-related (<italic>CDK4</italic>, <italic>MKI67</italic>) and cancer-related epithelial (<italic>KRT15</italic>, <italic>CD24</italic>) cell marker genes among each cluster (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). Notably, <italic>CDK4</italic> was highly expressed in P-Tex2 cells, cancer epithelial cells, and fibroblasts, while <italic>MKI67</italic> was highly expressed in P-Tex1 clusters. CDK4 is a well-known cancer treatment target, and CDK4 inhibitors (e.g., abemaciclib and palbociclib) have demonstrated cytostatic activity in HPV-negative HNSCC, whereas their effects on HPV-positive HNSCC are not obvious (<xref ref-type="bibr" rid="bib1">Adkins et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Oppelt et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Robinson et al., 2019</xref>). And it was interesting that HPV-positive HNSCC patients with higher <italic>CDK4</italic> expression levels showed better survival than patients with lower <italic>CDK4</italic> expression, whereas HPV-negative HNSCC patients with higher <italic>CDK4</italic> expression levels showed worse prognosis (<xref ref-type="fig" rid="fig5">Figure 5d</xref>). Besides, compared with HPV-negative patients, the proportion of P-Tex was higher in the TME of HPV-positive HNSCC patients (TCGA cohort, <xref ref-type="fig" rid="fig5">Figure 5e</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2c</xref>, <xref ref-type="supplementary-material" rid="supp9">Supplementary file 9</xref>). These findings raised the question of whether P-Tex cells that were beneficial to the prognosis of HPV-positive HNSCC patients would be simultaneously suppressed by CDK4 inhibitors.</p><p>To answer this question, we compared the cell viability of P-Tex cells and cancer epithelial cells by culturing with abemaciclib in vitro, respectively. As expected, abemaciclib inhibited the cell viability of both cancer cells (FD-LSC-1 cells) and P-Tex cells (<xref ref-type="fig" rid="fig5">Figure 5f</xref>). Therefore, we speculated that the inhibition of CDK4 inhibitor on the cell viability of P-Tex cells (which were beneficial to the survival prognosis of HPV-positive HNSCC patients) might be a potential reason why CDK4 inhibitors were ineffective in treating HPV-positive HNSCC patients.</p></sec><sec id="s2-6"><title>The cell–cell interactions between T cells and APCs in the HNSCC TME</title><p>To determine the underlying mechanism by which P-Tex cells fulfill their proliferation-related and anti-tumor function, we systematically explored the crosstalk between T cells and other cells in the HNSCC TME. The results showed that the interactions between P-Tex and Tex clusters and APCs (especially DCs) in the HNSCC TME were mainly enriched in T cell activation and proliferation signaling pathways, such as CD70-, CD80-, ICOS-, and PD-L1-related signaling pathways (<xref ref-type="fig" rid="fig6">Figure 6a–b</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref> and <xref ref-type="supplementary-material" rid="supp10">Supplementary file 10</xref>). Given the fact that the co-localization of APCs and T cells is the precondition for fulfilling their function related to antigen presentation and T cell activation, we further conducted spatial transcriptome (ST) analysis for representative fresh HNSCC tumor (P_08) to verify their spatial distribution characteristics. We identified 17 spatial cluster areas, among which cluster 16 were defined as APC area (<xref ref-type="fig" rid="fig6">Figure 6c</xref>). The P-Tex and Tex cells were characterized by the co-localization in the APC aggregation area with significantly higher P-Tex scores and Tex scores than other non-APC areas (p&lt;0.001), and the correlations among the three scores in the APC area were higher than those in other non-APC areas. As expected, the activation score of T cells were higher in APC area (<xref ref-type="fig" rid="fig6">Figure 6d–e</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>, <xref ref-type="supplementary-material" rid="supp11">Supplementary file 11</xref>). Besides, the aforementioned ligand–receptor interactions of T cell activation and proliferation signaling pathways (CD70-CD27, CD80-ICOS, CD86-CTLA4, CD274-PDCD1) were also detected in the APC areas (<xref ref-type="fig" rid="fig6">Figure 6f</xref>). We also observed enriched signaling pathways in APC areas involving the cell cycle, neutrophil activation, and RNA splicing (<xref ref-type="fig" rid="fig6">Figure 6g</xref>), supporting that these antigen-presenting cells play a role in modulating the immune response within the TME by promoting T cell activation (<xref ref-type="bibr" rid="bib34">Mehrfeld et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Wosen et al., 2018</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The cell–cell interactions between T cells and APC cells are enriched in the proliferation and cell activation pathways in head and neck squamous cell carcinoma (HNSCC) tumor microenvironment (TME).</title><p>(<bold>a</bold>) The communication probabilities mediated by selected ligand–receptor pairs among different cell types. The color gradient shows the level of interaction. (<bold>b</bold>) Network circle graphs visualize the inferred communication network of signaling pathways among different cell clusters derived by ligand–receptor interactions. The color of lines are consistent with the ligands. The width of lines are proportional to the interaction strength, and the circle sizes are proportional to the number of cells in each clusters. (<bold>c</bold>) The spatial transcriptomic landscape of representative HNSCC samples. (<bold>d–e</bold>) P-Tex and Tex features were co-expressed in APC area (cluster 16). The circles in SpatialDimPlot (<bold>d</bold>, left) represent APC, P-Tex, and Tex scores enriched in the APC area (cluster 16). The Texs and P-Tex scores were higher in the APC aggregation area (<bold>d</bold>, right). The correlation of P-Tex, Tex, activation scores, and APC scores in the spatial transcriptome (<bold>e</bold>). (<bold>f</bold>) Spatial feature plots of selected ligands–receptor interactions enriched in APC area. Spatial feature plots showing the expression pattern of single ligand genes (CD70, CD80, CD86, CD274, yellow spots), single receptor genes (CD27, ICOS, CTLA4, PDCD1, blue spots), and co-expression pattern (green spots) in APC area. (<bold>g</bold>) Gene ontology (GO) analysis identified the enriched gene functions in APC area of spatial transcriptome.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>The supplementary cell–cell interactions of head and neck squamous cell carcinoma (HNSCC) tumor microenvironment (TME) for <xref ref-type="fig" rid="fig6">Figure 6b</xref>.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>The correlation of Tex, P-Tex, and activation scores with APC scores for each cluster in spatial transcriptomics.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig6-figsupp2-v1.tif"/></fig></fig-group><p>To further confirm the ST results (transcriptomic level) at the proteomic level, we performed multiplex immunofluorescence (mIF) of both canonical APC markers (MHC-II<sup>+</sup>) and selected markers for P-Tex cells (CD8<sup>+</sup>PD1<sup>+</sup>CDK4<sup>+</sup>/MKI67<sup>+</sup>), bulk Tex cells (CD8<sup>+</sup>PD1<sup>+</sup>CDK4<sup>-</sup>MKI67<sup>-</sup>) and bulk CD8<sup>+</sup> T cells (CD8<sup>+</sup>) on formalin-fixed paraffin-embedded (FFPE) tissue originating from HNSCC patients (<xref ref-type="fig" rid="fig7">Figure 7a–b</xref>). Next, we explored average distances of APCs to P-Tex cells, bulk Tex cells, and bulk CD8<sup>+</sup> T cells (<xref ref-type="fig" rid="fig7">Figure 7c</xref>), respectively. As expected, 90% of the P-Tex cells, bulk Tex, and bulk CD8<sup>+</sup> cells enriched within a distance of 25 µm from APCs, forming an intra-tumoral niche (<xref ref-type="bibr" rid="bib25">Jansen et al., 2019</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>The spatial characteristics of APC, pro-Tex cells, and Tex cells in the head and neck squamous cell carcinoma (HNSCC) tumor microenvironment (TME).</title><p>(<bold>a–b</bold>) Representative example of HNSCC tumor stained by multiplex IHC, with white triangles and rhombus showing the Texs and P-Tex aggregates in the APC area, respectively. (<bold>c</bold>) Measured distances to APC (MHCII<sup>+</sup>) cells from CD8<sup>+</sup> T cells, CD8<sup>+</sup> PD1<sup>+</sup>T cells (Tex cells) or CD8<sup>+</sup> PD1<sup>+</sup>MKI67<sup>+</sup>/CDK4<sup>+</sup> T cells (P-Tex cells) in five representative samples. The dashed lines represent the cutoff distance of 25 μm, which indicate that 90% of CD8<sup>+</sup> T, Tex, or P-Tex cells are enriched within a distance of 25 µm from APCs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82705-fig7-v1.tif"/></fig><p>Taken together, P-Tex cells were enriched in the APC aggregation areas, and the signal pathways related to T cell activation and proliferation were activated in these areas, indicating that P-Tex might act as a specific T cell pool that provides modest but persistent effects through its interactions with APCs.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our current study provided a comprehensive multi-omics characterization of over 49,000 tumor-infiltrating CD3<sup>+</sup> T cells in HNSCC patients. A special novel P-Tex cluster that expressed high levels of proliferation- and cell cycle-related genes as well as cytotoxic and checkpoint molecules was identified. Our results showed that HPV-positive HNSCC patients who had higher proportions of P-Tex cells had a better survival prognosis. Unexpectedly, we also found that P-Tex cells expressed CDK4 genes as high as cancer cells, which could be simultaneously inhibited by the CDK4 inhibitors. Therefore, we speculated that it might be a potential reason for the ineffectiveness of CDK4 inhibitors in treating HPV-positive HNSCC. Furthermore, P-Tex cells were fund to be aggregated in the APC areas where their T cell activation and proliferation signaling pathways were activated. Together, our findings reveal a promising role for P-Tex cells in the prognosis of HPV-positive HNSCC patients by providing modest but persistent anti-tumor effects.</p><p>There is accumulating evidences showing that heterogeneity is a hallmark of T cell exhaustion, and a typical three-stage differentiation trajectory (progenitor–transitional–terminal) has been established to depict the corresponding spatiotemporally sequential alterations of gene signatures, functional characteristics, as well as epigenetic modifications (<xref ref-type="bibr" rid="bib8">Beltra et al., 2020</xref>; <xref ref-type="bibr" rid="bib24">Im and Ha, 2020</xref>). Despite several previous studies have identified similar proliferation Tex clusters in chronic LCMV-infected mouse models using scRNA-seq, little attention was paid to their potential roles in anti-tumor immunity (<xref ref-type="bibr" rid="bib35">Miller et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Wagle et al., 2021</xref>; <xref ref-type="bibr" rid="bib51">Yao et al., 2019</xref>). In this study, we systematically investigated the functional characteristics and developmental trajectory of P-Tex cells by comparing with other CD8<sup>+</sup> T cell clusters. Our results suggested that P-Tex was an independent branch of Tex cells and might act as a T cell pool, providing modest but persistent anti-tumor immunity through its prolonged cell survival and highly specialized cytotoxic capacity. However, this beneficial on long-term survival outcomes was only observed in HPV-positive HNSCC who had higher proportion of P-Tex.</p><p>CDK4/6 inhibitors (e.g., palbociclib, ribociclib, and abemaciclib) are promising drugs for various cancers (<xref ref-type="bibr" rid="bib16">Du et al., 2020</xref>), working by specifically inhibiting CDK4/6 proteins, blocking the transition from the G1 to the S phase of the cell cycle and preventing cancer cell progression (<xref ref-type="bibr" rid="bib4">Álvarez-Fernández and Malumbres, 2020</xref>). Notably, <italic>CDK4,</italic> which was highly expressed in cancer cells, was also found to be highly expressed in the P-Tex cells. Our in vitro results showed that CDK4 inhibitors could simultaneously inhibit the cell viability of both cancer cells and P-Tex cells. Due to the fact that P-Tex cells were benefit to the prognosis of HPV-positive HNSCC patients, we speculated that the inhibition of CDK4 inhibitors on P-Tex cells might be one of the reasons why promising treatment outcomes of CDK4 inhibitors were not observed in HPV-positive HNSCC patients (<xref ref-type="bibr" rid="bib1">Adkins et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Oppelt et al., 2021</xref>; <xref ref-type="bibr" rid="bib44">van Caloen and Machiels, 2019</xref>).</p><p>Overall, a novel promising P-Tex cluster, which was mainly identified in APC areas of TME, was beneficial to the survival prognosis of HPV-positive HNSCC,. Besides, the inhibitory effect of CDK4 inhibitors on P-Tex cells helps clarify its ineffectiveness in HPV-positive HNSCC patients.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Chromium Single Cell 5’ Gel Bead and Library Construction Kit</td><td align="left" valign="bottom">10× Genomics</td><td align="left" valign="bottom">PN-1000006;<break/>PN-1000020</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Single Cell V(D)J Enrichment Kit Human T cell</td><td align="left" valign="bottom">10× Genomics</td><td align="left" valign="bottom">PN-1000005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Visum Spatial Library Construction kit</td><td align="left" valign="bottom">10× Genomics</td><td align="left" valign="bottom">PN-1000184</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC Mouse Anti-Human CD3 (mouse monoclonal)</td><td align="left" valign="bottom">BD Pharmingen</td><td align="left" valign="bottom">Cat#555332</td><td align="left" valign="bottom">FACS (0.8 μL per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-human CD8a Antibody (mouse monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#300908, Clone: HIT8a</td><td align="left" valign="bottom">FACS (5 μL per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-human CD279 (PD-1) (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#329920</td><td align="left" valign="bottom">FACS (5 μL per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">UBE2C (B-8) PE (mouse monoclonal)</td><td align="left" valign="bottom">Santacruz</td><td align="left" valign="bottom">Cat#Sc271050</td><td align="left" valign="bottom">FACS (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE/Cyanine7 anti-human CD161 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Cat#339917</td><td align="left" valign="bottom">FACS (5 μL per test)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD8α (mouse monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#70306S</td><td align="left" valign="bottom">IHC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PD-1 (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#84,651T</td><td align="left" valign="bottom">IHC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Ki67 (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#ab16667, Clone: SP6</td><td align="left" valign="bottom">IHC (1:50)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CDK4 (Rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#12790</td><td align="left" valign="bottom">IHC (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CD24 (Rabbit Polyclonal)</td><td align="left" valign="bottom">Proteintech</td><td align="left" valign="bottom">Cat#10600-1-AP</td><td align="left" valign="bottom">IHC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HLA-DR (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#ab92511</td><td align="left" valign="bottom">IHC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-EpCAM (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#ab223582, Clone: EPR20532-225</td><td align="left" valign="bottom">IHC (1:500)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Cell Counting Kit-8</td><td align="left" valign="bottom">MedChemExpress</td><td align="left" valign="bottom">Cat#HY-K0301</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Manual Opal 7-Color IHC Kit</td><td align="left" valign="bottom">Akoyabio</td><td align="left" valign="bottom">Cat#NEL811001KT</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Laryngeal carcinoma</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">FD-LSC-1</td><td align="left" valign="bottom">Cell line maintained in State Key Laboratory of Biotherapy, West China Medical School, Sichuan University</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Abemaciclib (LY2835219)</td><td align="left" valign="bottom">Topscience</td><td align="left" valign="bottom">Cat#T2381</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cell Ranger count</td><td align="left" valign="bottom">10× Genomics</td><td align="left" valign="bottom">v3.1.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cell Ranger VDJ</td><td align="left" valign="bottom">10× Genomics</td><td align="left" valign="bottom">v6.1.1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Space Ranger</td><td align="left" valign="bottom">10× Genomics</td><td align="left" valign="bottom">v2.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seurat</td><td align="left" valign="bottom">R</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007322">SCR_007322</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">monocle3</td><td align="left" valign="bottom">R</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018685">SCR_018685</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CellChat</td><td align="left" valign="bottom">R</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_021946">SCR_021946</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">pheatmap</td><td align="left" valign="bottom">R</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016418">SCR_016418</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008520">SCR_008520</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Ethical statement</title><p>This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the Biomedical Research Ethics Committee of West China Hospital (2021-908), with the individual consent for each participant.</p></sec><sec id="s4-2"><title>Specimen collection and processing</title><p>Patient’s information was summarized in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. HNSCC tumor tissues and paired adjacent normal tissues were collected during the surgery. Then, the tissues were rinsed by 1× PBS, with surrounding necrotic areas being carefully removed and were cut into small pieces of 2–4 mm and reserved in the mixture of 1× DMEM medium (Gibco) and penicillin-streptomycin solution (Hyclone). The remaining tissues were fixed into FFPE blocks for HE staining and mIF.</p></sec><sec id="s4-3"><title>Preparation of single-cell suspensions</title><p>The tissue pieces were rapidly transferred into the gentleMACS C Tube containing Human Tumor Dissociation Kit (Miltenyi Biotec, #130-095-929) according to the manufacturer’s recommendation. The dissociated cells were filtered through 40 µm cell strainers to remove clumps. Cell pellets were resuspended in binding buffer after centrifuged and sorted via human CD3 MicroBeads (Miltenyi Biotec, #130-050-101) according to the manufacturer’s recommendation (Note: as for the experiment of scRNA-seq of overall cells, CD3 sorting was not needed). The overall cells and the sorted CD3<sup>+</sup> T cells were separately resuspended in HBSS (Gibco) plus 0.04% bovine serum albumin (Sigma-Aldrich) and tested for cell viability. Cell viability &gt;80% was required for subsequent library constructions.</p></sec><sec id="s4-4"><title>Library construction and sequencing</title><p>ScRNA-seq was performed using Chromium Single Cell 5’ Gel Bead and Library Construction Kit (10× Genomics, #PN-1000006, PN-1000020) and Single Cell V(D)J Enrichment Kit Human T cell (10× Genomics, #PN-1000005). Reverse transcription, cDNA recovery, cDNA amplification, and library construction were performed according to the manufacturer’s protocol. The constructed libraries were sequenced on NovaSeq 6000 (Illumina) with paired-end sequencing and single indexing.</p></sec><sec id="s4-5"><title>Quality control and preprocessing of sequencing data</title><p>Cell Ranger count (v3.0) (<xref ref-type="bibr" rid="bib52">Zheng et al., 2017</xref>) was used to process the raw FASTQ files, align the sequencing reads to Ensembl GRCh38 reference genome (<ext-link ext-link-type="uri" xlink:href="http://cf.10xgenomics.com/supp/cell-exp/refdata-cellranger-GRCh38-3.0.0.tar.gz">http://cf.10xgenomics.com/supp/cell-exp/refdata-cellranger-GRCh38-3.0.0.tar.gz</ext-link>), and exclude background noise to generate a filtered UMI expression matrix for each cell. The package Seurat (v4.0.4) (<xref ref-type="bibr" rid="bib21">Hao et al., 2021</xref>) were used to filter cells that were empty droplets or doublets and that have &gt;5% mitochondrial counts. Next, we normalized the expression matrix via ‘LogNormalize’ and log-transform method. Then, we apply a linear transformation to prepare the expression matrix for next step dimensional reduction.</p></sec><sec id="s4-6"><title>Unsupervised clustering of cells and UMAP visualization</title><p>The high cell-to-cell variable features (top 2000) between cells were used as input to perform principal component analysis on the scaled matrix. Subsequently, we employed Harmony (v1.0, R package) (<xref ref-type="bibr" rid="bib29">Korsunsky et al., 2019</xref>) to integrate multiple samples and the top 30 dimensions were selected for UMAP with the reduction of ‘harmony’.</p><p>We performed Seurat to cluster cells using the Louvain algorithm. The previous reported marker genes (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) were used for the cell cluster annotation with gene functional description and gene expression. Nebulosa (v1.3.0, R package) (<xref ref-type="bibr" rid="bib3">Alquicira-Hernandez and Powell, 2021</xref>) was applied to perform gene kernel density estimation and visualize cell features on UMAP plot.</p></sec><sec id="s4-7"><title>Differential expression and analysis of signaling pathways</title><p>To characterize the function of defined clusters, we used Seurat to calculate differentially expressed genes (DEGs) among each cluster, identified marker genes as DEGs with adjusted p-value &lt;0.05 and put marker genes into clusterProfiler (v4.0.2, R package) (<xref ref-type="bibr" rid="bib50">Wu et al., 2021</xref>) to perform GO enrichment analysis (p&lt;0.01) and GSEA and visualization.</p></sec><sec id="s4-8"><title>Transcription factor regulatory network analysis</title><p>To predict the gene regulatory network within cell clusters, we used previous selected top 2000 variable features-barcode matrix from scRNA-seq data as input and applied pySCENIC (v0.11.2) (<xref ref-type="bibr" rid="bib2">Aibar et al., 2017</xref>) to infer the network activity in each cell cluster.</p></sec><sec id="s4-9"><title>Cell score calculation</title><p>We applied AddModuleScore function embedded in Seurat to calculate the specific cell scores in different clusters, which was defined as: the average gene expression of specific gene panel in each cluster, subtract the average gene expression of random control gene sets (<xref ref-type="bibr" rid="bib39">Puram et al., 2017</xref>; <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Functional module scores were based on the expression levels of top 30 genes which were highly correlated with GZMB (cytotoxicity score), PDCD1 (exhaustion score), or MKI67 (proliferation), respectively. TCR-dependent T cell activation score was calculated based on the activation gene signature (<xref ref-type="bibr" rid="bib7">Azizi et al., 2018</xref>). Proliferation score was calculated based on the genes enriched in the GO molecular function term of ‘cell cycle phase transition’. The specific cluster score (P-Tex, Tex, and APC score) was calculated based on marker genes of each cluster listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p><p>We assigned cell cycle scores based on the expression of G2/M and S phase marker genes and predicted the classification of each cell in either G2/M, S, or G1 phase in the CellCycleScoring function embedded in Seurat.</p></sec><sec id="s4-10"><title>Trajectory analyses</title><p>To determine the potential development lineages of T cell subclusters, we converted the previous Seurat object into Monocle3 (v1.0.0, R package) (<xref ref-type="bibr" rid="bib14">Cao et al., 2019</xref>) object and inferred the trajectory of T cell subclusters at its proper position in pseudotime. Besides, to visualize the major non-linear components of variation across cells, we applied destiny package (v3.1.1, R package) (<xref ref-type="bibr" rid="bib6">Angerer et al., 2016</xref>) to perform the 3D diffusion maps to compute the diffusion components of each cell type.</p></sec><sec id="s4-11"><title>TCR clonotype analysis</title><p>Cell Ranger VDJ pipeline (v6.1.1, 10× Genomics) was used to process the raw TCR sequence data with default augments and align them to the Ensembl GRCh38 reference (<ext-link ext-link-type="uri" xlink:href="https://cf.10xgenomics.com/supp/cell-vdj/refdata-cellranger-vdj-GRCh38-alts-ensembl-5.0.0.tar.gz">https://cf.10xgenomics.com/supp/cell-vdj/refdata-cellranger-vdj-GRCh38-alts-ensembl-5.0.0.tar.gz</ext-link>). We performed scRepertoire (v1.3.2, R package) (<xref ref-type="bibr" rid="bib11">Borcherding et al., 2020</xref>) to integrate the TCR sequence data with mRNA expression data and used absolute frequency of V(D)J genes to define clonotype groups. The total frequency assigned for different extents of clonal expansion was categorized as follows: hyperexpanded (20 &lt; X ≤ 200), multiple (2 &lt; X ≤ 20), double (1 &lt; X ≤ 2), single (0 &lt; X ≤ 1).</p></sec><sec id="s4-12"><title>Ligand–receptor interactions</title><p>To understand communications among tumor cell clusters, we applied CellChat (v1.1.3, R package) (<xref ref-type="bibr" rid="bib26">Jin et al., 2021</xref>) to identify the cell–cell signaling links, inferred the cellular communication network and visualized the major ligand–receptor interaction between each cell cluster.</p></sec><sec id="s4-13"><title>Library construction of ST</title><p>Representative HNSCC tumor samples were collected for the spatial transcriptomic sequencing. Samples were cut into 6.5×6.5 mm<sup>2</sup> pieces, embedded in optimal cutting compound media and quickly frozen on dry ice. The frozen tissues were cryosectioned at 10 μm thickness by using the Thermo Scientific CryoStar NX50 cryostat and were placed in the capture area frames on the 10× Visium Spatial slides. Each sample slide was stained with H&amp;E (Hematoxylin Dako #S3309, Eosin, Dako #CS701, bluing buffer #CS702) and the brightfield images were captured via Leica whole-slide scanner at 10× resolution.</p><p>Following tissue permeabilization, reverse transcription and cDNA amplification were processed by using Reagent Kit (10× Genomics, #PN-1000184, PN-1000193). Visum spatial libraries were constructed using Visum Spatial Library Construction kit (10× Genomics, #PN-1000184) according to the manufacturer’s protocols. Finally, the libraries were sequenced using the Illumina NovaSeq6000 at least 100,000 reads per spot via pair-end 150 bp (PE150) reading strategy (performed by CapitalBio Technology, Beijing).</p></sec><sec id="s4-14"><title>Functional scoring and visualization of ST data</title><p>We performed alignment, filtering, barcode counting, and UMI counting by the Spaceranger count (v1.3.0) to generate feature-barcode matrix. We performed normalization, high-variance features detection (top 2000 genes), dimensionality reduction, and clusters identification (resolution = 1.0) for the spatially barcoded gene expression data via the standard Seurat pipeline. The P-Tex, Tex, and APC scoring algorithms of ST were similar to the module scoring algorithm of scRNA transcriptome (AddModuleScore) and the gene list of each module was listed in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>. Co-localization of P-Tex, Tex, and APC scores was verified by cor.test (stats, v3.6.2, R package) (<xref ref-type="bibr" rid="bib33">Maurage et al., 2013</xref>).</p></sec><sec id="s4-15"><title>Multiplex immunohistochemistry</title><p>Ten FFPE tissue of HNSCC tumors were sectioned to 4 µm thick for the subsequent multiplex immunohistochemistry via the OPAL Polaris system (Akoya Biosciences). After deparaffinization and hydration, the FFPE slides were manually stained with the CD8 (clone C8/144B, CST, #70306S), PD-1 (clone D7D5W, CST, #84,651T), anti-Ki67 (clone SP6, Abcam, #ab16667), CDK4 (clone D9G3E, CST, #12790), CD24 (10600-1-AP, Proteintech, #10600-1-AP), Anti-EPCAM (clone EPR20532-225, Abcam, #ab223582), and Anti-HLA-DR (clone EPR3692, Abcam, #ab92511) antibodies. The sections were counterstained with spectral DAPI (Akoya Biosciences). The stained slides were imaged and scanned using the Vectra Polaris multispectral imaging system.</p></sec><sec id="s4-16"><title>Cell staining strategies for flow cytometry</title><p>Single-cell suspensions (100 μL) of HNSCC tumor tissues were stained with CD3 (BD Pharmingen, #555332), CD8 (CST, #300908), PD1 (Biolegend, #329920), UBE2C (Santacruz, #Sc271050), and KLRB1 (Biolegend, #339917) antibodies at 4°C for 30 min under dark conditions. And 7-aminoactinomycin D (7AAD) was used for live/dead discrimination. P-Tex cells were defined as 7AAD-CD3<sup>+</sup>CD8<sup>+</sup>PD1<sup>+</sup> UBE2C<sup>+</sup> cells and T-Tex cells were defined as 7AAD-CD3<sup>+</sup>CD8<sup>+</sup>PD1<sup>+</sup>KLRB1<sup>+</sup>UBE2C<sup>-</sup> cells.</p></sec><sec id="s4-17"><title>In vivo cell function assays</title><sec id="s4-17-1"><title>Cell culture and proliferation assay</title><p>The sorted P-Tex cells and T-Tex cells were cultured in RPMI media containing 10% FBS, penicillin, streptomycin, and 20 IU/mL IL-2, and stimulated with T Cell TransAct (diluted at 1:100, T Cell TransAct, human, Miltenyi Biotec, #130-111-160), with fresh medium replaced every 3 days. After 14 consecutive days, proliferation rate of cells was assessed by flow cytometry.</p></sec><sec id="s4-17-2"><title>Survival assay</title><p>The sorted P-Tex and T-Tex cells were cultured in the RPMI media containing 10% FBS, human IL-2 (20 IU/mL), penicillin, and streptomycin in 96-well plates (15,000 cells/well). At the 5th, 10th, and 15th day of growth, cell counting was performed by flow cytometry. Cell viability was determined by propidium iodide (PI) staining on the 15th and 20th day of cell growth. And on the 9th and 16th day, P-Tex and T-Tex cells were stained by UBE2C (Santacruz, #Sc271050), PD1 (Biolegend, #329920), KLRB1 (Biolegend, #339917), and the protein expression was detected by flow cytometry. Software FlowJo was used for data analysis.</p></sec><sec id="s4-17-3"><title>CDK4/6 inhibition test</title><p>The sorted P-Tex and T-Tex cells (50,000 cells/well) and the cancer cell line (FD-LSC-1, 4000 cells/well, donated by State Key Laboratory of Biotherapy, West China Medical School, Sichuan University) (<xref ref-type="bibr" rid="bib31">Liu et al., 2020a</xref>) were transferred into 96-well plates, treated with Abemaciclib in gradient concentrations (0, 10, 100, and 500 nM) for 24, 48, and 72 hr, respectively. Cell proliferation was detected by Cell Counting Kit-8 (CCK-8) according to the manufacturer’s instruction. FD-LSC-1 cell line was authenticated by STR profiling. Cells were tested regularly for <italic>Mycoplasma</italic> contamination and none tested positive throughout the studies.</p></sec><sec id="s4-17-4"><title>Survival analysis</title><p>We further analyzed the transcriptome data of 500 HNSCC tumor samples (HPV negative: n=410; HPV positive: n=90) in TCGA cohort (<xref ref-type="bibr" rid="bib32">Liu et al., 2020b</xref>). Survival analysis related to gene expression level and functional module score in different HPV status was conducted through the Tumor Immune Estimation Resource (TIMER; <ext-link ext-link-type="uri" xlink:href="https://cistrome.shinyapps.io/timer">cistrome.shinyapps.io/timer</ext-link>) (<xref ref-type="bibr" rid="bib30">Li et al., 2017</xref>). Besides, to predict the proportion of P-Tex, Teff, and T-Tex cells in HPV-positive and HPV-negative HNSCC TCGA cohort, we used CIBERSORT software to deconvolve our scRNA-seq data (534 specific marker genes, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) into the TCGA bulk transcription data for clustering.</p></sec></sec><sec id="s4-18"><title>Statistical analysis</title><p>Statistical analysis was performed using R (v3.6.3). Wilcoxon rank-sum tests and Chi-square tests were used to compare variables. The hazard ratio and survival curves were estimated via a Cox regression model. A statistical significance was considered at p&lt;0.05.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Validation, Investigation, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con5"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Software, Formal analysis, Supervision, Funding acquisition, Investigation, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Software, Formal analysis</p></fn><fn fn-type="con" id="con11"><p>Software, Formal analysis, Supervision</p></fn><fn fn-type="con" id="con12"><p>Formal analysis, Supervision, Methodology</p></fn><fn fn-type="con" id="con13"><p>Resources, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con14"><p>Resources, Data curation, Methodology</p></fn><fn fn-type="con" id="con15"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con16"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con17"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con18"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con19"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con20"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con21"><p>Resources, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con22"><p>Data curation, Software, Validation, Methodology</p></fn><fn fn-type="con" id="con23"><p>Data curation, Software, Funding acquisition, Validation</p></fn><fn fn-type="con" id="con24"><p>Funding acquisition, Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con25"><p>Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con26"><p>Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con27"><p>Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con28"><p>Data curation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con29"><p>Data curation, Validation, Methodology</p></fn><fn fn-type="con" id="con30"><p>Resources, Data curation, Supervision, Funding acquisition, Validation</p></fn><fn fn-type="con" id="con31"><p>Resources, Data curation, Software, Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con32"><p>Data curation, Software, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con33"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the Biomedical Research Ethics Committee of West China Hospital (2021-908), with the individual consent for each participant.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Patients’ information.</title></caption><media xlink:href="elife-82705-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Cell numbers of single T cells from 14 head and neck squamous cell carcinoma (HNSCC) samples by single-cell RNA sequencing (scRNA-seq).</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp2-v1.xls"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Marker genes of different cell clusters applied in single-cell RNA sequencing (scRNA-seq).</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp3-v1.xls"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Transcriptional regulators of top expressed genes in each T cell clusters.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp4-v1.xls"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Functional cell scores of each cell cluster.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp5-v1.xls"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Numbers of shared clonotypes among each cell clusters.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp6-v1.xls"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>The overlap coefficients among each cluster.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp7-v1.xls"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>Cell numbers of different head and neck squamous cell carcinoma (HNSCC) tumor microenvironment (TME) subclusters by single-cell RNA sequencing (scRNA-seq).</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp8-v1.xls"/></supplementary-material><supplementary-material id="supp9"><label>Supplementary file 9.</label><caption><title>The proportion of P-Texs, T-Tex, and Teff clusters in HPV<sup>+</sup> and HPV<sup>-</sup> head and neck squamous cell carcinoma (HNSCC) samples in The Cancer Genome Atlas (TCGA) database.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp9-v1.xls"/></supplementary-material><supplementary-material id="supp10"><label>Supplementary file 10.</label><caption><title>The communication network of signaling pathways among different cell clusters derived by ligand–receptor interactions.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp10-v1.xls"/></supplementary-material><supplementary-material id="supp11"><label>Supplementary file 11.</label><caption><title>The P-Tex, Tex, and APC scores in spatial transcriptomic.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-82705-supp11-v1.xls"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-82705-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The raw sequence data reported in this paper have been deposited in the Genome Sequence Archive in National Genomics Data Center, China National Center for Bioinformation/Beijing Institute of Genomics, Chinese Academy of Sciences (GSA-Human: HRA003921) that are publicly accessible at <ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa-human">https://ngdc.cncb.ac.cn/gsa-human</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Qiu</surname><given-names>K</given-names></name><name><surname>Rao</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Single-cell Sequence Data of Human Papillomavirus Positive Head and Neck Squamous Cell Carcinoma</data-title><source>Genome Sequence Archive in National Genomics Data Center, China National Center for Bioinformation/Beijing Institute of Genomics, Chinese Academy of Sciences</source><pub-id pub-id-type="accession" xlink:href="https://ngdc.cncb.ac.cn/gsa-human/browse/HRA003921">HRA003921</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank the staff and students in the Department of Oto-Rhino-Laryngology, West China Biomedical Big Data Center, and Research Core Facility of West China Hospital for giving us kind support of sample collection and experiments. National Natural Youth Science Foundation of China grant 82002868 (RJJ). National Natural Youth Science Foundation of China grant 32100927 (YHP). China Postdoctoral Science Foundation grant 2020M673250 (RJJ). The Science and Technology Department of Sichuan Province grant 2022YFS0066 (ZYB). The Science and Technology Department of Sichuan Province grant 2020YFS0111 (RJJ). The Science and Technology Department of Sichuan Province grant 2021YFS0158 (YHP). West China Hospital, Sichuan University grant ZYJC21027 (ZY). West China Hospital, Sichuan University grant 2019HXBH079 (RJJ). Sichuan University grant 2020SCU12049 (RJJ). The Health Department of Sichuan Province grant 20PJ030 (RJJ).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adkins</surname><given-names>D</given-names></name><name><surname>Ley</surname><given-names>J</given-names></name><name><surname>Neupane</surname><given-names>P</given-names></name><name><surname>Worden</surname><given-names>F</given-names></name><name><surname>Sacco</surname><given-names>AG</given-names></name><name><surname>Palka</surname><given-names>K</given-names></name><name><surname>Grilley-Olson</surname><given-names>JE</given-names></name><name><surname>Maggiore</surname><given-names>R</given-names></name><name><surname>Salama</surname><given-names>NN</given-names></name><name><surname>Trinkaus</surname><given-names>K</given-names></name><name><surname>Van Tine</surname><given-names>BA</given-names></name><name><surname>Steuer</surname><given-names>CE</given-names></name><name><surname>Saba</surname><given-names>NF</given-names></name><name><surname>Oppelt</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial</article-title><source>The Lancet. Oncology</source><volume>20</volume><fpage>1295</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(19)30405-X</pub-id><pub-id pub-id-type="pmid">31351869</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>González-Blas</surname><given-names>CB</given-names></name><name><surname>Moerman</surname><given-names>T</given-names></name><name><surname>Huynh-Thu</surname><given-names>VA</given-names></name><name><surname>Imrichova</surname><given-names>H</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Rambow</surname><given-names>F</given-names></name><name><surname>Marine</surname><given-names>J-C</given-names></name><name><surname>Geurts</surname><given-names>P</given-names></name><name><surname>Aerts</surname><given-names>J</given-names></name><name><surname>van den Oord</surname><given-names>J</given-names></name><name><surname>Atak</surname><given-names>ZK</given-names></name><name><surname>Wouters</surname><given-names>J</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Scenic: single-cell regulatory network inference and clustering</article-title><source>Nature Methods</source><volume>14</volume><fpage>1083</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4463</pub-id><pub-id pub-id-type="pmid">28991892</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alquicira-Hernandez</surname><given-names>J</given-names></name><name><surname>Powell</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Nebulosa recovers single cell gene expression signals by kernel density estimation</article-title><source>Bioinformatics</source><volume>1</volume><elocation-id>btab003</elocation-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btab003</pub-id><pub-id pub-id-type="pmid">33459785</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Álvarez-Fernández</surname><given-names>M</given-names></name><name><surname>Malumbres</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mechanisms of sensitivity and resistance to CDK4/6 inhibition</article-title><source>Cancer Cell</source><volume>37</volume><fpage>514</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2020.03.010</pub-id><pub-id pub-id-type="pmid">32289274</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>KK</given-names></name><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>R</given-names></name><name><surname>Weber</surname><given-names>R</given-names></name><name><surname>Rosenthal</surname><given-names>DI</given-names></name><name><surname>Nguyen-Tân</surname><given-names>PF</given-names></name><name><surname>Westra</surname><given-names>WH</given-names></name><name><surname>Chung</surname><given-names>CH</given-names></name><name><surname>Jordan</surname><given-names>RC</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Axelrod</surname><given-names>R</given-names></name><name><surname>Silverman</surname><given-names>CC</given-names></name><name><surname>Redmond</surname><given-names>KP</given-names></name><name><surname>Gillison</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Human papillomavirus and survival of patients with oropharyngeal cancer</article-title><source>The New England Journal of Medicine</source><volume>363</volume><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0912217</pub-id><pub-id pub-id-type="pmid">20530316</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angerer</surname><given-names>P</given-names></name><name><surname>Haghverdi</surname><given-names>L</given-names></name><name><surname>Büttner</surname><given-names>M</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name><name><surname>Marr</surname><given-names>C</given-names></name><name><surname>Buettner</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Destiny: diffusion maps for large-scale single-cell data in R</article-title><source>Bioinformatics</source><volume>32</volume><fpage>1241</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv715</pub-id><pub-id pub-id-type="pmid">26668002</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azizi</surname><given-names>E</given-names></name><name><surname>Carr</surname><given-names>AJ</given-names></name><name><surname>Plitas</surname><given-names>G</given-names></name><name><surname>Cornish</surname><given-names>AE</given-names></name><name><surname>Konopacki</surname><given-names>C</given-names></name><name><surname>Prabhakaran</surname><given-names>S</given-names></name><name><surname>Nainys</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Kiseliovas</surname><given-names>V</given-names></name><name><surname>Setty</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>K</given-names></name><name><surname>Fromme</surname><given-names>RM</given-names></name><name><surname>Dao</surname><given-names>P</given-names></name><name><surname>McKenney</surname><given-names>PT</given-names></name><name><surname>Wasti</surname><given-names>RC</given-names></name><name><surname>Kadaveru</surname><given-names>K</given-names></name><name><surname>Mazutis</surname><given-names>L</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name><name><surname>Pe’er</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-Cell map of diverse immune phenotypes in the breast tumor microenvironment</article-title><source>Cell</source><volume>174</volume><fpage>1293</fpage><lpage>1308</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.060</pub-id><pub-id pub-id-type="pmid">29961579</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltra</surname><given-names>J-C</given-names></name><name><surname>Manne</surname><given-names>S</given-names></name><name><surname>Abdel-Hakeem</surname><given-names>MS</given-names></name><name><surname>Kurachi</surname><given-names>M</given-names></name><name><surname>Giles</surname><given-names>JR</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Casella</surname><given-names>V</given-names></name><name><surname>Ngiow</surname><given-names>SF</given-names></name><name><surname>Khan</surname><given-names>O</given-names></name><name><surname>Huang</surname><given-names>YJ</given-names></name><name><surname>Yan</surname><given-names>P</given-names></name><name><surname>Nzingha</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Amaravadi</surname><given-names>RK</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Karakousis</surname><given-names>GC</given-names></name><name><surname>Mitchell</surname><given-names>TC</given-names></name><name><surname>Schuchter</surname><given-names>LM</given-names></name><name><surname>Huang</surname><given-names>AC</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms</article-title><source>Immunity</source><volume>52</volume><fpage>825</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.04.014</pub-id><pub-id pub-id-type="pmid">32396847</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertoli</surname><given-names>C</given-names></name><name><surname>Skotheim</surname><given-names>JM</given-names></name><name><surname>de Bruin</surname><given-names>RAM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Control of cell cycle transcription during G1 and S phases</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>14</volume><fpage>518</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1038/nrm3629</pub-id><pub-id pub-id-type="pmid">23877564</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>CU</given-names></name><name><surname>Haining</surname><given-names>WN</given-names></name><name><surname>Held</surname><given-names>W</given-names></name><name><surname>Hogan</surname><given-names>PG</given-names></name><name><surname>Kallies</surname><given-names>A</given-names></name><name><surname>Lugli</surname><given-names>E</given-names></name><name><surname>Lynn</surname><given-names>RC</given-names></name><name><surname>Philip</surname><given-names>M</given-names></name><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Restifo</surname><given-names>NP</given-names></name><name><surname>Schietinger</surname><given-names>A</given-names></name><name><surname>Schumacher</surname><given-names>TN</given-names></name><name><surname>Schwartzberg</surname><given-names>PL</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Speiser</surname><given-names>DE</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Youngblood</surname><given-names>BA</given-names></name><name><surname>Zehn</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Defining “T cell exhaustion”</article-title><source>Nature Reviews Immunology</source><volume>19</volume><fpage>665</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0221-9</pub-id><pub-id pub-id-type="pmid">31570879</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borcherding</surname><given-names>N</given-names></name><name><surname>Bormann</surname><given-names>NL</given-names></name><name><surname>Kraus</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ScRepertoire: an R-based toolkit for single-cell immune receptor analysis</article-title><source>F1000Research</source><volume>9</volume><elocation-id>47</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.22139.2</pub-id><pub-id pub-id-type="pmid">32789006</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Torre</surname><given-names>LA</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA</source><volume>68</volume><fpage>394</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.3322/caac.21492</pub-id><pub-id pub-id-type="pmid">30207593</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brummelman</surname><given-names>J</given-names></name><name><surname>Pilipow</surname><given-names>K</given-names></name><name><surname>Lugli</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The single-cell phenotypic identity of human CD8(+) and CD4(+) T cells</article-title><source>International Review of Cell and Molecular Biology</source><volume>341</volume><fpage>63</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/bs.ircmb.2018.05.007</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Spielmann</surname><given-names>M</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Ibrahim</surname><given-names>DM</given-names></name><name><surname>Hill</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Mundlos</surname><given-names>S</given-names></name><name><surname>Christiansen</surname><given-names>L</given-names></name><name><surname>Steemers</surname><given-names>FJ</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The single-cell transcriptional landscape of mammalian organogenesis</article-title><source>Nature</source><volume>566</volume><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0969-x</pub-id><pub-id pub-id-type="pmid">30787437</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>ES</given-names></name><name><surname>Jenkins</surname><given-names>RW</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Dries</surname><given-names>R</given-names></name><name><surname>Yates</surname><given-names>K</given-names></name><name><surname>Chhabra</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Aref</surname><given-names>AR</given-names></name><name><surname>Ivanova</surname><given-names>E</given-names></name><name><surname>Paweletz</surname><given-names>CP</given-names></name><name><surname>Bowden</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>CW</given-names></name><name><surname>Herter-Sprie</surname><given-names>GS</given-names></name><name><surname>Sorrentino</surname><given-names>JA</given-names></name><name><surname>Bisi</surname><given-names>JE</given-names></name><name><surname>Lizotte</surname><given-names>PH</given-names></name><name><surname>Merlino</surname><given-names>AA</given-names></name><name><surname>Quinn</surname><given-names>MM</given-names></name><name><surname>Bufe</surname><given-names>LE</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Cavanaugh</surname><given-names>ME</given-names></name><name><surname>Rode</surname><given-names>AJ</given-names></name><name><surname>Haines</surname><given-names>E</given-names></name><name><surname>Roberts</surname><given-names>PJ</given-names></name><name><surname>Strum</surname><given-names>JC</given-names></name><name><surname>Richards</surname><given-names>WG</given-names></name><name><surname>Lorch</surname><given-names>JH</given-names></name><name><surname>Parangi</surname><given-names>S</given-names></name><name><surname>Gunda</surname><given-names>V</given-names></name><name><surname>Boland</surname><given-names>GM</given-names></name><name><surname>Bueno</surname><given-names>R</given-names></name><name><surname>Palakurthi</surname><given-names>S</given-names></name><name><surname>Freeman</surname><given-names>GJ</given-names></name><name><surname>Ritz</surname><given-names>J</given-names></name><name><surname>Haining</surname><given-names>WN</given-names></name><name><surname>Sharpless</surname><given-names>NE</given-names></name><name><surname>Arthanari</surname><given-names>H</given-names></name><name><surname>Shapiro</surname><given-names>GI</given-names></name><name><surname>Barbie</surname><given-names>DA</given-names></name><name><surname>Gray</surname><given-names>NS</given-names></name><name><surname>Wong</surname><given-names>K-K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cdk4/6 inhibition augments antitumor immunity by enhancing T-cell activation</article-title><source>Cancer Discovery</source><volume>8</volume><fpage>216</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-17-0915</pub-id><pub-id pub-id-type="pmid">29101163</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The application and prospect of cdk4/6 inhibitors in malignant solid tumors</article-title><source>Journal of Hematology &amp; Oncology</source><volume>13</volume><elocation-id>41</elocation-id><pub-id pub-id-type="doi">10.1186/s13045-020-00880-8</pub-id><pub-id pub-id-type="pmid">32357912</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Colombet</surname><given-names>M</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><name><surname>Mathers</surname><given-names>C</given-names></name><name><surname>Parkin</surname><given-names>DM</given-names></name><name><surname>Piñeros</surname><given-names>M</given-names></name><name><surname>Znaor</surname><given-names>A</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods</article-title><source>International Journal of Cancer</source><volume>144</volume><fpage>1941</fpage><lpage>1953</lpage><pub-id pub-id-type="doi">10.1002/ijc.31937</pub-id><pub-id pub-id-type="pmid">30350310</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galletti</surname><given-names>G</given-names></name><name><surname>De Simone</surname><given-names>G</given-names></name><name><surname>Mazza</surname><given-names>EMC</given-names></name><name><surname>Puccio</surname><given-names>S</given-names></name><name><surname>Mezzanotte</surname><given-names>C</given-names></name><name><surname>Bi</surname><given-names>TM</given-names></name><name><surname>Davydov</surname><given-names>AN</given-names></name><name><surname>Metsger</surname><given-names>M</given-names></name><name><surname>Scamardella</surname><given-names>E</given-names></name><name><surname>Alvisi</surname><given-names>G</given-names></name><name><surname>De Paoli</surname><given-names>F</given-names></name><name><surname>Zanon</surname><given-names>V</given-names></name><name><surname>Scarpa</surname><given-names>A</given-names></name><name><surname>Camisa</surname><given-names>B</given-names></name><name><surname>Colombo</surname><given-names>FS</given-names></name><name><surname>Anselmo</surname><given-names>A</given-names></name><name><surname>Peano</surname><given-names>C</given-names></name><name><surname>Polletti</surname><given-names>S</given-names></name><name><surname>Mavilio</surname><given-names>D</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Boi</surname><given-names>SK</given-names></name><name><surname>Youngblood</surname><given-names>BA</given-names></name><name><surname>Jones</surname><given-names>RE</given-names></name><name><surname>Baird</surname><given-names>DM</given-names></name><name><surname>Gostick</surname><given-names>E</given-names></name><name><surname>Llewellyn-Lacey</surname><given-names>S</given-names></name><name><surname>Ladell</surname><given-names>K</given-names></name><name><surname>Price</surname><given-names>DA</given-names></name><name><surname>Chudakov</surname><given-names>DM</given-names></name><name><surname>Newell</surname><given-names>EW</given-names></name><name><surname>Casucci</surname><given-names>M</given-names></name><name><surname>Lugli</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans</article-title><source>Nature Immunology</source><volume>21</volume><fpage>1552</fpage><lpage>1562</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0791-5</pub-id><pub-id pub-id-type="pmid">33046887</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gameiro</surname><given-names>SF</given-names></name><name><surname>Ghasemi</surname><given-names>F</given-names></name><name><surname>Barrett</surname><given-names>JW</given-names></name><name><surname>Koropatnick</surname><given-names>J</given-names></name><name><surname>Nichols</surname><given-names>AC</given-names></name><name><surname>Mymryk</surname><given-names>JS</given-names></name><name><surname>Maleki Vareki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Treatment-Naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy</article-title><source>Oncoimmunology</source><volume>7</volume><elocation-id>e1498439</elocation-id><pub-id pub-id-type="doi">10.1080/2162402X.2018.1498439</pub-id><pub-id pub-id-type="pmid">30288365</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goel</surname><given-names>S</given-names></name><name><surname>DeCristo</surname><given-names>MJ</given-names></name><name><surname>McAllister</surname><given-names>SS</given-names></name><name><surname>Zhao</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cdk4/6 inhibition in cancer: beyond cell cycle arrest</article-title><source>Trends in Cell Biology</source><volume>28</volume><fpage>911</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2018.07.002</pub-id><pub-id pub-id-type="pmid">30061045</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>JR</given-names></name><name><surname>Byeon</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development</article-title><source>Experimental &amp; Molecular Medicine</source><volume>52</volume><fpage>750</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1038/s12276-020-0435-8</pub-id><pub-id pub-id-type="pmid">32439954</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>SJ</given-names></name><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Gerner</surname><given-names>MY</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kissick</surname><given-names>HT</given-names></name><name><surname>Burger</surname><given-names>MC</given-names></name><name><surname>Shan</surname><given-names>Q</given-names></name><name><surname>Hale</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Nasti</surname><given-names>TH</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Freeman</surname><given-names>GJ</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Xue</surname><given-names>H-H</given-names></name><name><surname>Ahmed</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy</article-title><source>Nature</source><volume>537</volume><fpage>417</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/nature19330</pub-id><pub-id pub-id-type="pmid">27501248</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>SJ</given-names></name><name><surname>Ha</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Re-defining T-cell exhaustion: subset, function, and regulation</article-title><source>Immune Network</source><volume>20</volume><elocation-id>e2</elocation-id><pub-id pub-id-type="doi">10.4110/in.2020.20.e2</pub-id><pub-id pub-id-type="pmid">32158590</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>CS</given-names></name><name><surname>Prokhnevska</surname><given-names>N</given-names></name><name><surname>Master</surname><given-names>VA</given-names></name><name><surname>Sanda</surname><given-names>MG</given-names></name><name><surname>Carlisle</surname><given-names>JW</given-names></name><name><surname>Bilen</surname><given-names>MA</given-names></name><name><surname>Cardenas</surname><given-names>M</given-names></name><name><surname>Wilkinson</surname><given-names>S</given-names></name><name><surname>Lake</surname><given-names>R</given-names></name><name><surname>Sowalsky</surname><given-names>AG</given-names></name><name><surname>Valanparambil</surname><given-names>RM</given-names></name><name><surname>Hudson</surname><given-names>WH</given-names></name><name><surname>McGuire</surname><given-names>D</given-names></name><name><surname>Melnick</surname><given-names>K</given-names></name><name><surname>Khan</surname><given-names>AI</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Filson</surname><given-names>CP</given-names></name><name><surname>Alemozaffar</surname><given-names>M</given-names></name><name><surname>Osunkoya</surname><given-names>AO</given-names></name><name><surname>Mullane</surname><given-names>P</given-names></name><name><surname>Ellis</surname><given-names>C</given-names></name><name><surname>Akondy</surname><given-names>R</given-names></name><name><surname>Im</surname><given-names>SJ</given-names></name><name><surname>Kamphorst</surname><given-names>AO</given-names></name><name><surname>Reyes</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Kissick</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An intra-tumoral niche maintains and differentiates stem-like CD8 T cells</article-title><source>Nature</source><volume>576</volume><fpage>465</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1836-5</pub-id><pub-id pub-id-type="pmid">31827286</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Guerrero-Juarez</surname><given-names>CF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>I</given-names></name><name><surname>Ramos</surname><given-names>R</given-names></name><name><surname>Kuan</surname><given-names>CH</given-names></name><name><surname>Myung</surname><given-names>P</given-names></name><name><surname>Plikus</surname><given-names>MV</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inference and analysis of cell-cell communication using cellchat</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1088</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21246-9</pub-id><pub-id pub-id-type="pmid">33597522</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kansy</surname><given-names>BA</given-names></name><name><surname>Concha-Benavente</surname><given-names>F</given-names></name><name><surname>Srivastava</surname><given-names>RM</given-names></name><name><surname>Jie</surname><given-names>H-B</given-names></name><name><surname>Shayan</surname><given-names>G</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Moskovitz</surname><given-names>J</given-names></name><name><surname>Moy</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Brandau</surname><given-names>S</given-names></name><name><surname>Lang</surname><given-names>S</given-names></name><name><surname>Schmitt</surname><given-names>NC</given-names></name><name><surname>Freeman</surname><given-names>GJ</given-names></name><name><surname>Gooding</surname><given-names>WE</given-names></name><name><surname>Clump</surname><given-names>DA</given-names></name><name><surname>Ferris</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Pd-1 status in CD8+ T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer</article-title><source>Cancer Research</source><volume>77</volume><fpage>6353</fpage><lpage>6364</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-16-3167</pub-id><pub-id pub-id-type="pmid">28904066</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Park</surname><given-names>SM</given-names></name><name><surname>Cho</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Park</surname><given-names>YM</given-names></name><name><surname>Koh</surname><given-names>YW</given-names></name><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Ha</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptome analysis reveals tox as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer</article-title><source>Genome Medicine</source><volume>12</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-020-00722-9</pub-id><pub-id pub-id-type="pmid">32111241</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Millard</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Slowikowski</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>Baglaenko</surname><given-names>Y</given-names></name><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Loh</surname><given-names>P-R</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fast, sensitive and accurate integration of single-cell data with harmony</article-title><source>Nature Methods</source><volume>16</volume><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id><pub-id pub-id-type="pmid">31740819</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Traugh</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>JS</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Timer: a web server for comprehensive analysis of tumor-infiltrating immune cells</article-title><source>Cancer Research</source><volume>77</volume><fpage>e108</fpage><lpage>e110</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0307</pub-id><pub-id pub-id-type="pmid">29092952</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Proteomic characterization of proliferation inhibition of well-differentiated laryngeal squamous cell carcinoma cells under below-background radiation in a deep underground environment</article-title><source>Frontiers in Public Health</source><volume>8</volume><elocation-id>584964</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2020.584964</pub-id><pub-id pub-id-type="pmid">33194991</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Sadat</surname><given-names>SH</given-names></name><name><surname>Ebisumoto</surname><given-names>K</given-names></name><name><surname>Sakai</surname><given-names>A</given-names></name><name><surname>Panuganti</surname><given-names>BA</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Haft</surname><given-names>S</given-names></name><name><surname>Fukusumi</surname><given-names>T</given-names></name><name><surname>Ando</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Yeerna</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Hubbard</surname><given-names>J</given-names></name><name><surname>Sharabi</surname><given-names>AB</given-names></name><name><surname>Gutkind</surname><given-names>JS</given-names></name><name><surname>Califano</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Cannabinoids promote progression of HPV-positive head and neck squamous cell carcinoma via p38 MAPK activation</article-title><source>Clinical Cancer Research</source><volume>26</volume><fpage>2693</fpage><lpage>2703</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-3301</pub-id><pub-id pub-id-type="pmid">31932491</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurage</surname><given-names>P</given-names></name><name><surname>Heeren</surname><given-names>A</given-names></name><name><surname>Pesenti</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Does chocolate consumption really boost Nobel Award chances? the peril of over-interpreting correlations in health studies</article-title><source>The Journal of Nutrition</source><volume>143</volume><fpage>931</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.3945/jn.113.174813</pub-id><pub-id pub-id-type="pmid">23616517</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehrfeld</surname><given-names>C</given-names></name><name><surname>Zenner</surname><given-names>S</given-names></name><name><surname>Kornek</surname><given-names>M</given-names></name><name><surname>Lukacs-Kornek</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The contribution of non-professional antigen-presenting cells to immunity and tolerance in the liver</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>635</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00635</pub-id><pub-id pub-id-type="pmid">29643856</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>BC</given-names></name><name><surname>Sen</surname><given-names>DR</given-names></name><name><surname>Al Abosy</surname><given-names>R</given-names></name><name><surname>Bi</surname><given-names>K</given-names></name><name><surname>Virkud</surname><given-names>YV</given-names></name><name><surname>LaFleur</surname><given-names>MW</given-names></name><name><surname>Yates</surname><given-names>KB</given-names></name><name><surname>Lako</surname><given-names>A</given-names></name><name><surname>Felt</surname><given-names>K</given-names></name><name><surname>Naik</surname><given-names>GS</given-names></name><name><surname>Manos</surname><given-names>M</given-names></name><name><surname>Gjini</surname><given-names>E</given-names></name><name><surname>Kuchroo</surname><given-names>JR</given-names></name><name><surname>Ishizuka</surname><given-names>JJ</given-names></name><name><surname>Collier</surname><given-names>JL</given-names></name><name><surname>Griffin</surname><given-names>GK</given-names></name><name><surname>Maleri</surname><given-names>S</given-names></name><name><surname>Comstock</surname><given-names>DE</given-names></name><name><surname>Weiss</surname><given-names>SA</given-names></name><name><surname>Brown</surname><given-names>FD</given-names></name><name><surname>Panda</surname><given-names>A</given-names></name><name><surname>Zimmer</surname><given-names>MD</given-names></name><name><surname>Manguso</surname><given-names>RT</given-names></name><name><surname>Hodi</surname><given-names>FS</given-names></name><name><surname>Rodig</surname><given-names>SJ</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Haining</surname><given-names>WN</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade</article-title><source>Nature Immunology</source><volume>20</volume><fpage>326</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0312-6</pub-id><pub-id pub-id-type="pmid">30778252</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Näsman</surname><given-names>A</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Dalianis</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A global epidemic increase of an HPV-induced tonsil and tongue base cancer-potential benefit from a pan-gender use of HPV vaccine</article-title><source>Journal of Internal Medicine</source><volume>287</volume><fpage>134</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1111/joim.13010</pub-id><pub-id pub-id-type="pmid">31733108</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oppelt</surname><given-names>P</given-names></name><name><surname>Ley</surname><given-names>JC</given-names></name><name><surname>Worden</surname><given-names>F</given-names></name><name><surname>Palka</surname><given-names>K</given-names></name><name><surname>Maggiore</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Adkins</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: a multicenter phase 2 trial</article-title><source>Oral Oncology</source><volume>114</volume><elocation-id>105164</elocation-id><pub-id pub-id-type="doi">10.1016/j.oraloncology.2020.105164</pub-id><pub-id pub-id-type="pmid">33465681</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poropatich</surname><given-names>K</given-names></name><name><surname>Fontanarosa</surname><given-names>J</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Dittmann</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Samant</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV) -positive and HPV-negative head and neck squamous cell carcinomas</article-title><source>The Journal of Pathology</source><volume>243</volume><fpage>354</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1002/path.4953</pub-id><pub-id pub-id-type="pmid">28771750</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puram</surname><given-names>SV</given-names></name><name><surname>Tirosh</surname><given-names>I</given-names></name><name><surname>Parikh</surname><given-names>AS</given-names></name><name><surname>Patel</surname><given-names>AP</given-names></name><name><surname>Yizhak</surname><given-names>K</given-names></name><name><surname>Gillespie</surname><given-names>S</given-names></name><name><surname>Rodman</surname><given-names>C</given-names></name><name><surname>Luo</surname><given-names>CL</given-names></name><name><surname>Mroz</surname><given-names>EA</given-names></name><name><surname>Emerick</surname><given-names>KS</given-names></name><name><surname>Deschler</surname><given-names>DG</given-names></name><name><surname>Varvares</surname><given-names>MA</given-names></name><name><surname>Mylvaganam</surname><given-names>R</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Rocco</surname><given-names>JW</given-names></name><name><surname>Faquin</surname><given-names>WC</given-names></name><name><surname>Lin</surname><given-names>DT</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-Cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer</article-title><source>Cell</source><volume>171</volume><fpage>1611</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.10.044</pub-id><pub-id pub-id-type="pmid">29198524</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>AM</given-names></name><name><surname>Rathore</surname><given-names>R</given-names></name><name><surname>Redlich</surname><given-names>NJ</given-names></name><name><surname>Adkins</surname><given-names>DR</given-names></name><name><surname>VanArsdale</surname><given-names>T</given-names></name><name><surname>Van Tine</surname><given-names>BA</given-names></name><name><surname>Michel</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cisplatin exposure causes c-myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma</article-title><source>Cell Death &amp; Disease</source><volume>10</volume><elocation-id>867</elocation-id><pub-id pub-id-type="doi">10.1038/s41419-019-2098-8</pub-id><pub-id pub-id-type="pmid">31727874</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero-Pozuelo</surname><given-names>J</given-names></name><name><surname>Figlia</surname><given-names>G</given-names></name><name><surname>Kaya</surname><given-names>O</given-names></name><name><surname>Martin-Villalba</surname><given-names>A</given-names></name><name><surname>Teleman</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cdk4 and cdk6 couple the cell-cycle machinery to cell growth via mtorc1</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107504</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.03.068</pub-id><pub-id pub-id-type="pmid">32294430</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>SM</given-names></name><name><surname>Sage</surname><given-names>J</given-names></name><name><surname>Skotheim</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Integrating old and new paradigms of G1/S control</article-title><source>Molecular Cell</source><volume>80</volume><fpage>183</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.08.020</pub-id><pub-id pub-id-type="pmid">32946743</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanchot</surname><given-names>C</given-names></name><name><surname>Terme</surname><given-names>M</given-names></name><name><surname>Pere</surname><given-names>H</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>Benhamouda</surname><given-names>N</given-names></name><name><surname>Strioga</surname><given-names>M</given-names></name><name><surname>Banissi</surname><given-names>C</given-names></name><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name><name><surname>Tartour</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Tumor-Infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance</article-title><source>Cancer Microenvironment</source><volume>6</volume><fpage>147</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1007/s12307-012-0122-y</pub-id><pub-id pub-id-type="pmid">23104434</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Caloen</surname><given-names>G</given-names></name><name><surname>Machiels</surname><given-names>J-P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of squamous cell carcinoma of the head and neck</article-title><source>Current Opinion in Oncology</source><volume>31</volume><fpage>122</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1097/CCO.0000000000000513</pub-id><pub-id pub-id-type="pmid">30986809</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagle</surname><given-names>MV</given-names></name><name><surname>Vervoort</surname><given-names>SJ</given-names></name><name><surname>Kelly</surname><given-names>MJ</given-names></name><name><surname>Van Der Byl</surname><given-names>W</given-names></name><name><surname>Peters</surname><given-names>TJ</given-names></name><name><surname>Martin</surname><given-names>BP</given-names></name><name><surname>Martelotto</surname><given-names>LG</given-names></name><name><surname>Nüssing</surname><given-names>S</given-names></name><name><surname>Ramsbottom</surname><given-names>KM</given-names></name><name><surname>Torpy</surname><given-names>JR</given-names></name><name><surname>Knight</surname><given-names>D</given-names></name><name><surname>Reading</surname><given-names>S</given-names></name><name><surname>Thia</surname><given-names>K</given-names></name><name><surname>Miosge</surname><given-names>LA</given-names></name><name><surname>Howard</surname><given-names>DR</given-names></name><name><surname>Gloury</surname><given-names>R</given-names></name><name><surname>Gabriel</surname><given-names>SS</given-names></name><name><surname>Utzschneider</surname><given-names>DT</given-names></name><name><surname>Oliaro</surname><given-names>J</given-names></name><name><surname>Powell</surname><given-names>JD</given-names></name><name><surname>Luciani</surname><given-names>F</given-names></name><name><surname>Trapani</surname><given-names>JA</given-names></name><name><surname>Johnstone</surname><given-names>RW</given-names></name><name><surname>Kallies</surname><given-names>A</given-names></name><name><surname>Goodnow</surname><given-names>CC</given-names></name><name><surname>Parish</surname><given-names>IA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>2782</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-23044-9</pub-id><pub-id pub-id-type="pmid">33986293</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>XJ</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>HH</given-names></name><name><surname>Dong</surname><given-names>ZY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hpv-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>13404</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-49771-0</pub-id><pub-id pub-id-type="pmid">31527697</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wansom</surname><given-names>D</given-names></name><name><surname>Light</surname><given-names>E</given-names></name><name><surname>Worden</surname><given-names>F</given-names></name><name><surname>Prince</surname><given-names>M</given-names></name><name><surname>Urba</surname><given-names>S</given-names></name><name><surname>Chepeha</surname><given-names>DB</given-names></name><name><surname>Cordell</surname><given-names>K</given-names></name><name><surname>Eisbruch</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>D’Silva</surname><given-names>N</given-names></name><name><surname>Moyer</surname><given-names>J</given-names></name><name><surname>Bradford</surname><given-names>CR</given-names></name><name><surname>Kurnit</surname><given-names>D</given-names></name><name><surname>Kumar</surname><given-names>B</given-names></name><name><surname>Carey</surname><given-names>TE</given-names></name><name><surname>Wolf</surname><given-names>GT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer</article-title><source>Archives of Otolaryngology--Head &amp; Neck Surgery</source><volume>136</volume><fpage>1267</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1001/archoto.2010.211</pub-id><pub-id pub-id-type="pmid">21173378</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Kurachi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Molecular and cellular insights into T cell exhaustion</article-title><source>Nature Reviews. Immunology</source><volume>15</volume><fpage>486</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1038/nri3862</pub-id><pub-id pub-id-type="pmid">26205583</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wosen</surname><given-names>JE</given-names></name><name><surname>Mukhopadhyay</surname><given-names>D</given-names></name><name><surname>Macaubas</surname><given-names>C</given-names></name><name><surname>Mellins</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Epithelial MHC class II expression and its role in antigen presentation in the gastrointestinal and respiratory tracts</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>2144</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02144</pub-id><pub-id pub-id-type="pmid">30319613</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Bo</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data</article-title><source>Innovation</source><volume>2</volume><elocation-id>100141</elocation-id><pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id><pub-id pub-id-type="pmid">34557778</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>H-W</given-names></name><name><surname>Lacey</surname><given-names>NE</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Moseman</surname><given-names>EA</given-names></name><name><surname>Shih</surname><given-names>H-Y</given-names></name><name><surname>Heuston</surname><given-names>EF</given-names></name><name><surname>Kirby</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>O</given-names></name><name><surname>Handon</surname><given-names>R</given-names></name><name><surname>Reilley</surname><given-names>J</given-names></name><name><surname>Fioravanti</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Gossa</surname><given-names>S</given-names></name><name><surname>Wherry</surname><given-names>EJ</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>McGavern</surname><given-names>DB</given-names></name><name><surname>O’Shea</surname><given-names>JJ</given-names></name><name><surname>Schwartzberg</surname><given-names>PL</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell RNA-seq reveals tox as a key regulator of CD8+ T cell persistence in chronic infection</article-title><source>Nature Immunology</source><volume>20</volume><fpage>890</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0403-4</pub-id><pub-id pub-id-type="pmid">31209400</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>GXY</given-names></name><name><surname>Terry</surname><given-names>JM</given-names></name><name><surname>Belgrader</surname><given-names>P</given-names></name><name><surname>Ryvkin</surname><given-names>P</given-names></name><name><surname>Bent</surname><given-names>ZW</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Ziraldo</surname><given-names>SB</given-names></name><name><surname>Wheeler</surname><given-names>TD</given-names></name><name><surname>McDermott</surname><given-names>GP</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Gregory</surname><given-names>MT</given-names></name><name><surname>Shuga</surname><given-names>J</given-names></name><name><surname>Montesclaros</surname><given-names>L</given-names></name><name><surname>Underwood</surname><given-names>JG</given-names></name><name><surname>Masquelier</surname><given-names>DA</given-names></name><name><surname>Nishimura</surname><given-names>SY</given-names></name><name><surname>Schnall-Levin</surname><given-names>M</given-names></name><name><surname>Wyatt</surname><given-names>PW</given-names></name><name><surname>Hindson</surname><given-names>CM</given-names></name><name><surname>Bharadwaj</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Ness</surname><given-names>KD</given-names></name><name><surname>Beppu</surname><given-names>LW</given-names></name><name><surname>Deeg</surname><given-names>HJ</given-names></name><name><surname>McFarland</surname><given-names>C</given-names></name><name><surname>Loeb</surname><given-names>KR</given-names></name><name><surname>Valente</surname><given-names>WJ</given-names></name><name><surname>Ericson</surname><given-names>NG</given-names></name><name><surname>Stevens</surname><given-names>EA</given-names></name><name><surname>Radich</surname><given-names>JP</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Hindson</surname><given-names>BJ</given-names></name><name><surname>Bielas</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Massively parallel digital transcriptional profiling of single cells</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14049</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14049</pub-id><pub-id pub-id-type="pmid">28091601</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82705.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Kellie N</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>The Johns Hopkins University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.10.27.513993" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.27.513993"/></front-stub><body><p>This study provides fundamental insight into the functional impact of CDK4 inhibition on cells in the tumor microenvironment, which is of high importance and interest to the field. The compelling conclusion that proliferative exhausted T cells are associated with response in HPV+ head and neck cancer is supported by the cohort of 14 patients with paired tumor and adjacent normal tissue and rigorous bioinformatic analysis of nearly 50,000 single CD3+ T cell transcriptomes. This work will be of interest to researchers across tumor types and in other immunological fields of study.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82705.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Smith</surname><given-names>Kellie N</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>The Johns Hopkins University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.27.513993">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.10.27.513993v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Proliferative Exhausted CD8 T Cells Exacerbate Long-lasting Anti-tumor Effects in Human Papillomavirus Positive Head and Neck Squamous Cell Carcinoma&quot; for consideration by eLife. Your article has been reviewed by 1 peer reviewer, and the evaluation has been overseen by a Reviewing Editor and Tadatsugu Taniguchi as the Senior Editor. The reviewer has opted to remain anonymous.</p><p>The Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Temper some claims as indicated in the reviewer comments, ensuring that the conclusions are supported by the data presented.</p><p>2) Clarify the use of TCRseq to ensure TCR-based conclusions are biologically relevant.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82705.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Temper some claims as indicated in the reviewer comments, ensuring that the conclusions are supported by the data presented.</p><p>2) Clarify the use of TCRseq to ensure TCR-based conclusions are biologically relevant.</p></disp-quote><p>With the kind help from you, the paper has been carefully revised and all the comments are fully dealt with. Specifically, we have tempered some claims as indicated in the reviewers’ comments, ensuring that the conclusions are supported by the data presented. And we especially clarified the use of TCRseq to ensure TCR-based conclusions are biologically relevant.</p></body></sub-article></article>